Investigación en Enfermedades Infecciosas

Lopez Lopez A, Alonso Dominguez J, Martinez Barros I, Perez Gonzalez A, OcampoA, Morano L, Calderon Cruz B, Martinez Lopez de Castro N, Bisbal Pardo O,Perez-Olmeda M, Sanchez-Villegas J, Asensi V, Montero-Alonso M, Rodriguez-RosadoMartinez-Echevarria R, Poveda E; CoRIS Cohort. Elevated Plasma GDF-15 Levels AreAssociated with Aging, Multimorbidity, and Tobacco Exposure in People with HIV.Infect Dis Ther. 2026 Mar;15(3):715-731. doi: 10.1007/s40121-026-01302-x. Epub2026 Jan 21. PubMed PMID: 41563586; PubMed Central PMCID: PMC12924802.

Lopez Lopez A, Perez Gonzalez A, Alonso Dominguez J, Ocampo A, Miralles C,Morano L, Aguayo Arjona J, Martinez Lopez de Castro N, Poveda E. High prevalenceof polypharmacy and nervous system medications in people with HIV: across-sectional analysis. Sci Rep. 2026 Jan 27;16(1):6413. doi:10.1038/s41598-026-36832-4. PubMed PMID: 41593305; PubMed Central PMCID:PMC12910090.

Berenguer J, Jarrin I, Bellon JM, Diez C, Jimenez-Sousa MA, Lopez JC,Pinto-Martinez A, Moreno S, Montes ML, Iribarren JA, Orviz E, Portilla J,Villarroya F, Domingo P, Resino S; CoRIS Cohort (Eva Poveda, Alexandre Pérez, Luis Morano). Mitochondrial Haplogroups and Weight Gain After Initiating ART in Patients With HIV. J Infect Dis. 2024 Aug16;230(2):421-425. doi: 10.1093/infdis/jiae168. PubMed PMID: 38557859.

Chacon F, Morano L, Navarro J, Granados R, Llibre JM, Ryan P,Aldamiz-Echevarria T, Carbonero LM, Puigvehi M, Clotet-Codina I, Sanchez-Vega N,Vacas E, Rincon O, Berenguer J, Crespo J, Roncero C. Rate of hepatitis Creinfection after successful direct-acting antivirals treatment among people whoinject drugs in Spain: the LIVERate study. BMC Public Health. 2024 Nov14;24(1):3167. doi: 10.1186/s12889-024-20625-3. PubMed PMID: 39543579; PubMedCentral PMCID: PMC11566421.

Collazos J, Perez-Is L, de la Fuente B, Morano L, Rivas-Carmenado M, RodriguezM, Romero-Favela A, de Jesus Fonseca-Gonzalez G, Melon S, Diaz-Arias J,Valle-Garay E, Asensi V. No gender differences in the 24-month course ofnon-invasive liver fibrosis markers after DAA therapy in HCV-mono andHCV/HIV-coinfected patients. Sci Rep. 2024 Mar 29;14(1):7534. doi:10.1038/s41598-024-57845-x. PubMed PMID: 38553507; PubMed Central PMCID:PMC10980728.

Corma-Gomez A, Cabello A, Orviz E, Morante-Ruiz M, Ayerdi O, Al-Hayani A,Munoz-Gomez A, Santos IL, Gomez-Ayerbe C, Rodrigo D, Riestra SR, Reus-Banuls S,Silva-Klug A, Galindo MJ, Santos M, Serrano-Fuentes M, Faro-Miguez N,Perez-Camacho I, Corona-Mata D, Morano L, Lopez-Ruz MA, Montero M, Anaya-Baz B,Merino D, Castillo-Navarro A, Pineda JA, Macias J. Long or complicated mpox inpatients with uncontrolled HIV infection. J Med Virol. 2024 Mar;96(3):e29511.doi: 10.1002/jmv.29511. PubMed PMID: 38469884.

De la Rosa-Riestra S, Lopez-Hernandez I, Perez-Rodriguez MT, Sousa A,Goikoetxea Agirre J, Reguera Iglesias JM, Leon E, Arminanzas Castillo C, SanchezGomez L, Fernandez-Natal I, Fernandez-Suarez J, Boix-Palop L, Cuquet Pedragosa J,Jover-Saenz A, Sanchez Calvo JM, Martin-Aspas A, Natera-Kindelan C, Del ArcoJimenez A, Bahamonde Carrasco A, Amat AS, Vinuesa Garcia D, Martinez Perez-CrespoPM, Lopez-Cortes LE, Rodriguez-Bano J; PROBAC/GEIRAS-SEIMC/SAMICEI. Acomprehensive, predictive mortality score for patients with bloodstreaminfections (PROBAC): a prospective, multicentre cohort study. J AntimicrobChemother. 2024 Aug 1;79(8):1794-1800. doi: 10.1093/jac/dkae093. PubMed PMID:38863341.

De la Rosa-Riestra S, Martinez Perez-Crespo PM, Perez Rodriguez MT, Sousa A,Goikoetxea J, Reguera Iglesias JM, Arminanzas C, Lopez-Hernandez I, Lopez-CortesLE, Rodriguez-Bano J; PROBAC group. Mortality impact of further delays in activetargeted antibiotic therapy in bacteraemic patients that did not receive initialactive empiric treatment: Results from the prospective, multicentre cohortPROBAC. Int J Infect Dis. 2024 Aug;145:107072. doi: 10.1016/j.ijid.2024.107072.Epub 2024 May 1. PubMed PMID: 38701915.

Escrihuela-Vidal F, Palacios-Baena ZR, Agirre JG, Perez-Rodriguez MT, RegueraIglesias JM, Cuquet Pedragosa J, Sanchez Gomez L, Boix-Palop L, BahamondeCarrasco A, Natera-Kindelan C, Fernandez-Suarez J, Jover-Saenz A, Smithson AmatA, Del Arco Jimenez A, Sanchez Calvo JM, Martin-Aspas A, Martinez Perez-CrespoPM, Lopez-Hernandez I, Rodriguez-Bano J, Lopez-Cortes LE;PROBAC/GEIRAS-SEIMC/SAMICEI group. Early antibiotic de-escalation in patientswith severe infections due to bloodstream infection by enterobacterales: A posthoc analysis of a prospective multicentre cohort. Int J Antimicrob Agents. 2024Nov;64(5):107317. doi: 10.1016/j.ijantimicag.2024.107317. Epub 2024 Sep 2. PubMedPMID: 39233214.

Guedes M, Gathara D, Lopez-Hernandez I, Perez-Crespo PMM, Perez-Rodriguez MT,Sousa A, Plata A, Reguera-Iglesias JM, Boix-Palop L, Dietl B, Blanco JS, CastilloCA, Galan-Sanchez F, Kindelan CN, Jover-Saenz A, Aguirre JG, Aleman AA, CiordiaTM, Del Arco Jimenez A, Fernandez-Suarez J, Lopez-Cortes LE, Rodriguez-Bano J;PROBAC/GEIRAS-SEIMC/SAMICEI group. Differences in clinical outcomes ofbloodstream infections caused by Klebsiella aerogenes, Klebsiella pneumoniae andEnterobacter cloacae: a multicentre cohort study. Ann Clin Microbiol Antimicrob.2024 May 6;23(1):42. doi: 10.1186/s12941-024-00700-8. PubMed PMID: 38711045;PubMed Central PMCID: PMC11071190.

Hou J, Zhang W, Xie Q, Hua R, Tang H, Morano Amado LE, Yang SS, Peng CY, SuWW, Chuang WL, Kim DJ, Avihingsanon A, Kao JH, Leerapun A, Yuen MF, Asselah T,Liang X, Bo Q, Canducci F, Catanese MT, Chen E, Cheng C, Chughlay F, Das S,Glavini K, Guerreiro N, Huang Y, Kakrana P, Kazma R, Patil A, Pavlovic V,Surujbally B, Triyatni M, Upmanyu R, Wat C, Gane E; Piranga Study Group.Xalnesiran with or without an Immunomodulator in Chronic Hepatitis B. N Engl JMed. 2024 Dec 5;391(22):2098-2109. doi: 10.1056/NEJMoa2405485. PubMed PMID:39774313.

Landete P, Caliman-Sturdza OA, Lopez-Martin JA, Preotescu L, Luca MC,Kotanidou A, Villares P, Iglesias SP, Guisado-Vasco P, Saiz-Lou EM, Del CarmenFarinas-Alvarez M, de Lucas EM, Perez-Alba E, Cisneros JM, Estrada V,Hidalgo-Tenorio C, Poulakou G, Torralba M, Fortun J, Garcia-Ocana P, Lemaignen A,Marcos-Martin M, Molina M, Paredes R, Perez-Rodriguez MT, Raev D, Ryan P, MeiraF, Gomez J, Torres N, Lopez-Mendoza D, Jimeno J, Varona JF. A Phase IIIRandomized Controlled Trial of Plitidepsin, a Marine-Derived Compound, inHospitalized Adults With Moderate COVID-19. Clin Infect Dis. 2024 Oct15;79(4):910-919. doi: 10.1093/cid/ciae227. PubMed PMID: 39182994; PubMed CentralPMCID: PMC11478586.

Lopez-Cortes LE, Delgado-Valverde M, Moreno-Mellado E, Goikoetxea Aguirre J,Guio Carrion L, Blanco Vidal MJ, Lopez Soria LM, Perez-Rodriguez MT, MartinezLamas L, Arnaiz de Las Revillas F, Arminanzas C, Ruiz de Alegria-Puig C, JimenezAguilar P, Del Carmen Martinez-Rubio M, Saez-Bejar C, de Las Cuevas C,Martin-Aspas A, Galan F, Yuste JR, Leiva-Leon J, Bou G, Capon Gonzalez P,Boix-Palop L, Xercavins-Valls M, Goenaga-Sanchez MA, Anza DV, Caston JJ, RufianMR, Merino E, Rodriguez JC, Loeches B, Cuervo G, Guerra Laso JM, Plata A, PerezCortes S, Lopez Mato P, Sierra Monzon JL, Rosso-Fernandez C, Bravo-Ferrer JM,Retamar-Gentil P, Rodriguez-Bano J; SIMPLIFY study group. Efficacy and safety ofa structured de-escalation from antipseudomonal beta-lactams in bloodstreaminfections due to Enterobacterales (SIMPLIFY): an open-label, multicentre,randomised trial. Lancet Infect Dis. 2024 Apr;24(4):375-385. doi:10.1016/S1473-3099(23)00686-2. Epub 2024 Jan 9. PubMed PMID: 38215770.

Perez-Gonzalez A, Rodriguez-Rivero S, Fernandez-Veiga P, Flores E, Poveda E,Gonzalez-Carrero J, Perez-Castro S, Labajo-Leal L, Miralles C, Ocampo A. AnalDysplasia Screening in People Living with HIV: Long-Term Follow-Up in a LargeCohort from Northwest Spain. AIDS Patient Care STDS. 2024 Jan;38(1):5-13. doi:10.1089/apc.2023.0231. Epub 2023 Dec 20. PubMed PMID: 38117576; PubMed CentralPMCID: PMC10794828.

Perez-Rodriguez MT, Lima O, Garrido M, Rincon A, Martinez-Lamas L,Perez-Gonzalez A, Araujo A, Amoedo A, Sousa A, Lopez A, Cabrera X, Rubianes M.The role of time to positive blood cultures in enhancing the predictivecapability of DENOVA score for diagnosing infective endocarditis in patients withEnterococcus faecalis bacteremia. Eur J Clin Microbiol Infect Dis. 2024Jul;43(7):1481-1486. doi: 10.1007/s10096-024-04843-6. Epub 2024 May 20. PubMedPMID: 38763988.

Scharloo F, Cogliati Dezza F, Lopez-Hernandez I, Martinez Perez-Crespo PM,Goikoetxea Aguirre AJ, Perez-Rodriguez MT, Fernandez-Suarez J, Leon Jimenez E,Moran Rodriguez MA, Fernandez-Natal I, Reguera Iglesias JM, Natera Kindelan C,Farinas Alvares MC, Boix-Palop L, Lopez-Cortes LE, Rodriguez-Bano J;PROBAC/GEIRAS-SEIMC/SAMICEI group. Clinical characteristics, predisposing factorsand outcomes for Enterococcus faecalis versus Enterococcus faecium bloodstreaminfections: a prospective multicentre cohort study. Eur J Clin Microbiol InfectDis. 2024 Oct;43(10):2011-2022. doi: 10.1007/s10096-024-04917-5. Epub 2024 Aug 8.PubMed PMID: 39112668; PubMed Central PMCID: PMC11405461.

Suarez M, Perez-Landeiro A, Sanjurjo A, Lima O, Sousa A, Lopez A,Martinez-Lamas L, Cabrera X, Rubianes M, Perez-Rodriguez MT. Comparison ofdalbavancin with standard of care in the management of infective endocarditis:efficacy, safety, and cost analysis. Int J Infect Dis. 2024 Jan;138:41-45. doi:10.1016/j.ijid.2023.11.003. Epub 2023 Nov 4. PubMed PMID: 37931892.

Avila-Nunez M, Lima O, Sousa A, Represa M, Rubinan P, Celestino P,Garrido-Ventin M, Garcia-Formoso L, Vasallo-Vidal F, Martinez-Lamas L,Perez-Landeiro A, Rubianes M, Perez-Rodriguez MT. Carbapenem alternatives fortreatment of bloodstream infections due to AmpC producing enterobacterales. AnnClin Microbiol Antimicrob. 2023 Aug 17;22(1):75. doi: 10.1186/s12941-023-00624-9.PubMed PMID: 37592268; PubMed Central PMCID: PMC10436381.

Badia-Cebada L, Carmezim J, Perez-Rodriguez MT, Bereciartua E, Lopez LE,Montenegro MR, Pomar V, Andres M, Petkova E, Sopena N, Lora-Tamayo J, MonsalvezV, Ramirez-Hidalgo MF, Gomez-Zorrilla S, Boix L, Meije Y, Jimenez E, Gasch O.Randomized Clinical Trial of the Need for Antibiotic Treatment for Low-RiskCatheter-Related Bloodstream Infection Caused by Coagulase-NegativeStaphylococci. Antibiotics (Basel). 2023 May 1;12(5):839. doi:10.3390/antibiotics12050839. PubMed PMID: 37237744; PubMed Central PMCID:PMC10215141.

Benavent E, Kortajarena X, Sobrino-Diaz B, Gasch O, Rodriguez-Pardo D,Escudero-Sanchez R, Bahamonde A, Rodriguez-Montserrat D, Garcia-Pais MJ, Del ToroLopez MD, Sorli L, Nodar A, Vilchez HH, Munez E, Iribarren JA, Ariza J, MurilloO; Group for the Study of Osteoarticular Infections – Spanish Society ofInfectious Diseases and Clinical Microbiology (GEIO-SEIMC). Vertebralosteomyelitis after spine instrumentation surgery: risk factors and management. JHosp Infect. 2023 Oct;140:102-109. doi: 10.1016/j.jhin.2023.07.008. Epub 2023 Jul22. PubMed PMID: 37482096.

Castillo-Fernandez N, Perez-Crespo PMM, Salamanca-Rivera E, Herrera-Hidalgo L,de Alarcon A, Navarro-Amuedo MD, Marrodan Ciordia T, Perez-Rodriguez MT,Sevilla-Blanco J, Jover-Saenz A, Fernandez-Suarez J, Arminanzas-Castillo C,Reguera-Iglesias JM, Natera Kindelan C, Boix-Palop L, Leon Jimenez E,Galan-Sanchez F, Del Arco Jimenez A, Bahamonde-Carrasco A, Vinuesa Garcia D,Smithson Amat A, Cuquet Pedragosa J, Reche Molina IM, Perez Camacho I, Merino deLucas E, Gutierrez-Gutierrez B, Rodriguez Bano J, Lopez Cortes LE. ConventionalHospitalization versus Sequential Outpatient Parenteral Antibiotic Therapy forStaphylococcus aureus Bacteremia: Post-Hoc Analysis of a MulticenterObservational Cohort. Antibiotics (Basel). 2023 Jan 9;12(1):129. doi:10.3390/antibiotics12010129. PubMed PMID: 36671330; PubMed Central PMCID:PMC9854520.

Cercenado E, Rodriguez-Bano J, Alfonso JL, Calbo E, Escosa L, Fernandez-PoloA, Garcia-Rodriguez J, Garnacho J, Gil-Navarro MV, Grau S, Gudiol C, HorcajadaJP, Larrosa N, Martinez C, Molina J, Nuvials X, Oliver A, Pano-Pardo JR,Perez-Rodriguez MT, Ramirez P, Rey-Biel P, Vidal P, Retamar-Gentil P.Antimicrobial stewardship in hospitals: Expert recommendation guidance documentfor activities in specific populations, syndromes and other aspects (PROA-2) fromSEIMC, SEFH, SEMPSPGS, SEMICYUC and SEIP. Enferm Infecc Microbiol Clin (Engl Ed).2023 Apr;41(4):238-242. doi: 10.1016/j.eimce.2022.05.013. Epub 2023 Jan 5. PubMedPMID: 36610836.

González Rodríguez L, Marín E, Rodríguez Fernández V, Miralles Álvarez C. La importancia de conocer la salud sexual de las mujeres que conviven con el Virus de la Inmunodeficiencia Humana. Revista Multidisciplinar del Sida. 2023;11(29):30-40. https://dialnet.unirioja.es/servlet/articulo?codigo=8953238

Martinez-Camprecios J, Riveiro-Barciela M, Munoz-Gomez R, Londono MC, Roget M,Serra MA, Escudero-Garcia D, Purchades L, Rodriguez M, Losa-Garcia JE, GutierrezML, Carmona I, Garcia-Samaniego J, Morano L, Martin-Granizo I, Montero-Alonso M,Prieto M, Delgado M, Ramos N, Azancot MA, Rodriguez-Frias F, Buti M. Long-termfollow-up of HCV-infected patients with end-stage chronic kidney disease aftersustained virological response with direct-acting antiviral therapy.Gastroenterol Hepatol. 2023 Oct;46(8):594-602. doi:10.1016/j.gastrohep.2022.12.004. Epub 2022 Dec 27. English, Spanish. PubMed PMID:36584754.

Martinez-Sanz J, Diaz-Alvarez J, Rosas M, Ron R, Iribarren JA, Bernal E,Gutierrez F, Ruiz Sancho A, Cabello N, Olalla J, Moreno S, Serrano-Villar S;CoRIS [Eva Poveda, Alexandre Pérez, Luis Morano, Celia Miralles, Antonio Ocampo, Guillermo Pousada, Lucía Patiño]. Expanding HIV clinical monitoring: the role of CD4, CD8, and CD4/CD8 ratioin predicting non-AIDS events. EBioMedicine. 2023 Sep;95:104773. doi:10.1016/j.ebiom.2023.104773. Epub 2023 Aug 26. PubMed PMID: 37639938; PubMedCentral PMCID: PMC10474064.

Nunez-Fernandez M, Ramos-Hernandez C, Garcia-Rio F, Perez-Gonzalez A,Tilve-Gomez A, Rodriguez-Fernandez P, Nodar-Germinas A, Fernandez-Garcia A,Ruano-Ravina A, Fernandez-Villar A. Evolution and long?term respiratory sequelaeafter severe COVID-19 pneumonia: nitric oxide diffusion measurement value. RespirRes. 2023 Feb 13;24(1):48. doi: 10.1186/s12931-023-02344-2. PubMed PMID:36782191; PubMed Central PMCID: PMC9924196.

Nunez-Pereira S, Benavent E, Ulldemolins M, Sobrino-Diaz B, Iribarren JA,Escudero-Sanchez R, Del Toro MD, Nodar A, Sorli L, Bahamonde A, Vilchez HH, GaschO, Munez E, Rodriguez-Montserrat D, Garcia-Pais MJ, Haddad S, Sellares-Nadal J,Murillo O, Rodriguez-Pardo D, On Behalf Of Geio-Seimc Group For The Study OfOsteoarticular Infections-Spanish Society Of Infectious Diseases And ClinicalMicrobiology. Cutibacterium spp. Infections after Instrumented SpineSurgery Have a Good Prognosis Regardless of Rifampin Use: A Cross-SectionalStudy. Antibiotics (Basel). 2023 Mar 4;12(3):518. doi:10.3390/antibiotics12030518. PubMed PMID: 36978385; PubMed Central PMCID:PMC10044575.

Pascale R, Toschi A, Aslan AT, Massaro G, Maccaro A, Fabbricatore D,Dell’Aquila A, Ripa M, Isik ME, Kizmaz YU, Iacopino S, Camici M, Perna F,Akinosoglou K, Karruli A, Papadimitriou-Olivgeris M, Kayaaslan B, Bilir YA, EvrenOzcan E, Turan OE, Isik MC, Perez-Rodriguez MT, Yague BL, Quiros AM, Yilmaz M,Petersdorf S, De Potter T, Durante-Mangoni E, Akova M, Curnis A, Gibertoni D,Diemberger I, Scudeller L, Viale P, Giannella M; CarDINe Study Group. Riskfactors for Gram-negative bacterial infection of cardiovascular implantableelectronic devices: multicentre observational study (CarDINe Study). Int JAntimicrob Agents. 2023 Mar;61(3):106734. doi: 10.1016/j.ijantimicag.2023.106734.Epub 2023 Jan 21. PubMed PMID: 36690123.

Perez-Gonzalez A, Carballo R, Araujo-Ameijeiras A, Abad R, Navarro C, OcampoA, Poveda E, Potel C. Meningococcal carriage in men who have sex with menpresenting at a sexual health unit in Spain. Eur J Clin Microbiol Infect Dis.2023 Mar;42(3):287-296. doi: 10.1007/s10096-023-04550-8. Epub 2023 Jan 24. PubMedPMID: 36692604.

Soriano A, Montravers P, Bassetti M, Klyasova G, Daikos G, Irani P, Stone G,Chambers R, Peeters P, Shah M, Hulin C, Albuquerque N, Basin E, Gaborit B,Kourbeti I, Menichetti F, Perez-Rodriguez MT, Pletz MW, Sanchez M, Trompa I,Verma A, de Figueiredo MLN, Charbonneau C. The Use and Effectiveness ofCeftazidime-Avibactam in Real-World Clinical Practice: EZTEAM Study. Infect DisTher. 2023 Mar;12(3):891-917. doi: 10.1007/s40121-023-00762-9. Epub 2023 Feb 10.PubMed PMID: 36763243; PubMed Central PMCID: PMC9912999.

Sousa, Adrián MD?,†; Lima, Olalla MD?,†; Pérez-González, Alexandre MD?,‡; Araujo, Alejandro MD†; Longueira, Rebeca MD?,†; Otero, Antón MD?; Núñez, Marta MD§; Ramos, Cristina MD§; Martínez-Lamas, Lucía MD?; Crespo-Casal, Manuel MD?; Rubianes, Martin MD?; Pérez-Rodríguez, María Teresa MD?,†. Impact of Methylprednisolone Pulse on the Mortality of Patients With Acute Respiratory Distress Syndrome Secondary to COVID-19. Infectious Diseases in Clinical Practice 31(6):e1296, November 2023. | DOI: 10.1097/IPC.0000000000001296

Suarez M, Calvo-Iglesias F, Sousa A, Lima O, Longueira R, Lopez A, Rubianes M,Perez-Rodriguez MT. A Confounder in the Study of a Patient With InfectiveEndocarditis. JACC Case Rep. 2023 Oct 27;28:102095. doi:10.1016/j.jaccas.2023.102095. eCollection 2023 Dec 20. PubMed PMID: 38204549;PubMed Central PMCID: PMC10774786.

Alvarez H, Rava M, Martinez C, Portilla J, Peraire J, Rivero A, Cervero M,Marino A, Poveda E, Llibre JM; CoRIS Study (Alexandre Pérez, Manuel Crespo, Luis Morano, Celia Miralles, Antonio Ocampo, Guillermo Pousada). Predictors of low-level HIVviraemia and virological failure in the era of integrase inhibitors: A Spanishnationwide cohort. HIV Med. 2022 Sep;23(8):825-836. doi: 10.1111/hiv.13265. Epub2022 Mar 1. PubMed PMID: 35234328.

Araujo L, Martinez-Romo J, Bisbal O, Sanchez-de-Madariaga R; Cohort of theNational AIDS Network (CoRIS) (Luis Morano). Discovering HIV related information by means ofassociation rules and machine learning. Sci Rep. 2022 Oct 28;12(1):18208. doi:10.1038/s41598-022-22695-y. PubMed PMID: 36307506; PubMed Central PMCID:PMC9616424.

Calleja JL, Aguilera A, Buti M, Crespo J, Garcia F, Jorquera F, Morano LE,Macias J, Lazarus JV. Ten steps to eliminating hepatitis C in hospitals. Nat RevGastroenterol Hepatol. 2022 Aug;19(8):481-483. doi: 10.1038/s41575-022-00647-1.No abstract available. PubMed PMID: 35739353.

Fanciulli C, Berenguer J, Busca C, Vivancos MJ, Tellez MJ, Dominguez L,Domingo P, Navarro J, Santos J, Iribarren JA, Morano L, Artero A, Moreno J,Rivero-Roman A, Santos I, Giner L, Arminanzas C, Montero M, Manzardo C, CifuentesC, Garcia C, Galindo MJ, Ferrero OL, Sanz J, de la Fuente B, Rodriguez C, GasparG, Perez L, Losa JE, Force L, Veloso S, Martinez-Alfaro E, Jarrin I, De Miguel M,Gonzalez Garcia J; GeSIDA 8514 Study Group. Epidemiological trends of HIV/HCVcoinfection in Spain, 2015-2019. HIV Med. 2022 Aug;23(7):705-716. doi:10.1111/hiv.13229. Epub 2022 Jan 17. PubMed PMID: 35037379; PubMed Central PMCID:PMC9543728.

Lima O, Sousa A, Filgueira A, Gonzalez-Novoa MC, Dominguez-Lopez C,Avila-Nunez M, Represa M, Rubinan P, Martinez-Lamas L, Perez-Castro S, RubianesM, Perez-Rodriguez MT. Gastrointestinal colonization by OXA-48-producingEnterobacterales: risk factors for persistent carriage. Eur J Clin MicrobiolInfect Dis. 2022 Dec;41(12):1399-1405. doi: 10.1007/s10096-022-04504-6. Epub 2022Oct 7. PubMed PMID: 36205803.

Lima O, Sousa A, Filgueira A, Otero A, Cabaleiro A, Martinez-Lamas L, VasalloF, Perez-Rodriguez MT. Successful ceftazidime-avibactam therapy in a patient withmultidrug-resistant Pseudomonas aeruginosa infective endocarditis. Infection.2022 Aug;50(4):1039-1041. doi: 10.1007/s15010-022-01834-7. Epub 2022 Apr 17. Noabstract available. PubMed PMID: 35430686.

Lima O, Sousa A, Longueira-Suarez R, Filgueira A, Taboada-Martinez C,Portela-Pino C, Nodar A, Vasallo-Vidal F, Martinez-Lamas L, Perez-Landeiro A,Rubianes M, Perez-Rodriguez MT. Ceftazidime-avibactam treatment in bacteremiacaused by OXA-48 carbapenemase-producing Klebsiella pneumoniae. Eur J ClinMicrobiol Infect Dis. 2022 Sep;41(9):1173-1182. doi: 10.1007/s10096-022-04482-9.Epub 2022 Aug 8. PubMed PMID: 35939239.

Martinez Lamas L, Diz Dios P, Perez Rodriguez MT, Del Campo Perez V, CabreraAlvargonzalez JJ, Lopez Dominguez AM, Fernandez Feijoo J, Diniz Freitas M,Limeres Posse J. Is povidone iodine mouthwash effective against SARS-CoV-2? Firstin vivo tests. Oral Dis. 2022 Apr;28 Suppl 1(Suppl 1):908-911. doi:10.1111/odi.13526. Epub 2020 Jul 29. No abstract available. PubMed PMID:32615642; PubMed Central PMCID: PMC7362147.
Enlace

Perez-Gonzalez A, Cachay E, Ocampo A, Poveda E. Update on the EpidemiologicalFeatures and Clinical Implications of Human Papillomavirus Infection (HPV) andHuman Immunodeficiency Virus (HIV) Coinfection. Microorganisms. 2022 May18;10(5):1047. doi: 10.3390/microorganisms10051047. PubMed PMID: 35630489; PubMedCentral PMCID: PMC9147826.

Perez-Gonzalez A, Represa M, Coll P, Potel C, Rodriguez-Rivero S, Flores EV,Vazquez-Estevez C, Ocampo A, Pousada G, Poveda E. Real-life cohort experienceafter implementing HIV pre-exposure prophylaxis for one year in northwest Spain.Front Public Health. 2022 Oct 28;10:1005622. doi: 10.3389/fpubh.2022.1005622.eCollection 2022. PubMed PMID: 36388349; PubMed Central PMCID: PMC9650222.

Perez-Gonzalez A, Suarez-Garcia I, Ocampo A, Poveda E. Two-Drug Regimens forHIV-Current Evidence, Research Gaps and Future Challenges. Microorganisms. 2022Feb 14;10(2):433. doi: 10.3390/microorganisms10020433. PubMed PMID: 35208887;PubMed Central PMCID: PMC8880461.

Perez-Is L, Collazos J, de la Fuente B, Morano L, Rivas-Carmenado M, RodriguezM, Romero-Favela A, Fonseca-Gonzalez GJ, Melon S, Valle-Garay E, Asensi V.24-month decline of non-invasive liver fibrosis markers in HCV-mono and HCV/HIVcoinfection after direct-acting antiviral therapy. Sci Rep. 2022 Mar9;12(1):3828. doi: 10.1038/s41598-022-07548-y. PubMed PMID: 35264591; PubMedCentral PMCID: PMC8907337.

Poveda E, Tabernilla A, Fitzgerald W, Salgado-Barreira Á, Grandal M, Pérez A, Mariño A, Álvarez H, Valcarce N, González-García J, Bernardino JI, Gutierrez F, Fujioka H, Crespo M, Ruiz-Mateos E, Margolis L, Lederman MM, Freeman ML. Massive Release of CD9+ Microvesicles in Human Immunodeficiency Virus Infection, Regardless of Virologic Control. J Infect Dis. 2022 Jun;225(6):1040–9. PMID: 32603406. DOI: 10.1093/infdis/jiaa375. http://www.ncbi.nlm.nih.gov/pubmed/32603406
Enlace

Rubinan P, Perez-Rodriguez MT, Dominguez A, Sousa A, Lima O, Rubianes M, CondeC, Alvarez-Fernandez M. Oral sequential therapy in the treatment of post-surgicalepidural abscess and subdural empyema. Infection. 2022 Oct;50(5):1385-1389. doi:10.1007/s15010-022-01814-x. Epub 2022 Apr 23. PubMed PMID: 35460496.

Solo-Peleteiro A, Dieguez P, Perez-Rodriguez MT, Galarraga RA, Perez-LandeiroA, Alvarez-Fernandez M. Cerebrospinal fluid drainage-related ventriculitis due tomultidrug-resistant microorganisms. Enferm Infecc Microbiol Clin (Engl Ed). 2022Jun-Jul;40(6):322-325. doi: 10.1016/j.eimce.2020.12.005. PubMed PMID: 35680350.

Spuch C, Lopez-Garcia M, Rivera-Baltanas T, Cabrera-Alvargonzalez JJ, Gadh S,Rodrigues-Amorim D, Alvarez-Estevez T, Mora A, Iglesias-Martinez-Almeida M,Freiria-Martinez L, Perez-Rodriguez M, Perez-Gonzalez A, Lopez-Dominguez A,Longueira-Suarez MR, Sousa-Dominguez A, Araujo-Ameijeiras A, Mosquera-RodriguezD, Crespo M, Vila-Fernandez D, Regueiro B, Olivares JM. Efficacy and Safety ofLithium Treatment in SARS-CoV-2 Infected Patients. Front Pharmacol. 2022 Apr14;13:850583. doi: 10.3389/fphar.2022.850583. eCollection 2022. PubMed PMID:35496309; PubMed Central PMCID: PMC9046673.

Velicia Penas C, Del Campo Perez VM, Rivero Calle I, Armenteros Del Olmo L,Perez Rodriguez MT, Gestal Otero JJ. [Expert opinion on strategies to improvevaccination coverage against seasonal influenza]. Rev Esp Quimioter. 2022Oct;35(5):435-443. doi: 10.37201/req/031.2022. Epub 2022 Jun 21. Spanish. PubMedPMID: 35726347; PubMed Central PMCID: PMC9548073.

Wedemeyer H, Di Marco V, Garcia-Retortillo M, Teti E, Fraser C, Morano AmadoLE, Rodriguez-Tajes S, Acosta-Lopez S, O’Loan J, Milella M, Buti M, Guerra-VelozMF, Ramji A, Fenech M, Martins A, Borgia SM, Vanstraelen K, Mertens M, HernandezC, Ntalla I, Ramroth H, Milligan S. Global Real-World Evidence ofSofosbuvir/Velpatasvir as a Highly Effective Treatment and Elimination Tool inPeople with Hepatitis C Infection Experiencing Mental Health Disorders. Viruses.2022 Nov 11;14(11):2493. doi: 10.3390/v14112493. PubMed PMID: 36423102; PubMedCentral PMCID: PMC9695390.

Antela A, Rivero A, Llibre JM, Moreno S, RET Group [Celia Miralles]. Redefining therapeutic success in HIV patients: an expert view. J Antimicrob Chemother. 2021;76(10):2501–18. PMID: 34077524. DOI: 10.1093/jac/dkab168. http://www.ncbi.nlm.nih.gov/pubmed/34077524
Enlace

Bacqué J, Delgado E, Benito S, Moreno-Lorenzo M, Montero V, Gil H, Sánchez M, Nieto-Toboso MC, Muñoz J, Zubero-Sulibarria MZ, Ugalde E, García-Bodas E, Cañada JE, Del Romero J, Rodríguez C, Rodríguez-Avial I, Elorduy-Otazua L, Portu JJ, García-Costa J, Ocampo A, Cabrera JJ, Thomson MM. Identification of CRF66_BF, a New HIV-1 Circulating Recombinant Form of South American Origin. Front Microbiol. 2021;12:774386. PMID: 34867914. DOI: 10.3389/fmicb.2021.774386. http://www.ncbi.nlm.nih.gov/pubmed/34867914
Enlace

Benavent E, Rodríguez-Pardo D, Ulldemolins M, Sobrino-Diaz B, Bustinduy MJ, Escudero-Sanchez R, Nodar A, Sorli L, Del Toro López MD, Bahamonde A, Vilchez HH, Duran J, Muñez E, Rodriguez-Montserrat D, García-País MJ, Pellisé F, Núñez-Pereira S, Caballero-Martinez LF, Cobo J, Pérez-Rodríguez MT, Ariza J, Pigrau C, Murillo O, REIPI (Spanish Network for Research in Infectious Disease)/GEIO–SEIMC (Group for the Study of Osteoarticular Infections – Spanish Society of Infectious Diseases and Clinical Microbiology). Infections after spine instrumentation: effectiveness of short antibiotic treatment in a large multicentre cohort. J Antimicrob Chemother. 2021 Mar;76(4):1085–93. PMID: 33496335. DOI: 10.1093/jac/dkaa548. http://www.ncbi.nlm.nih.gov/pubmed/33496335
Enlace

Berzosa Sánchez A, Jiménez De Ory S, Frick MA, Menasalvas Ruiz AI, Couceiro JA, Mellado MJ, Bisbal O, Albendin Iglesias H, Montero M, Roca C, Samperiz G, Cervero M, Miralles C, Fortuny Guash C, Carrasco I, Navarro ML, Ramos Amador JT, Corispe-Faro Cohort Working Group S. Mortality in Perinatally HIV-infected Adolescents After Transition to Adult Care in Spain. Pediatr Infect Dis J. 2021;40(4):347–50. PMID: 33264211. DOI: 10.1097/INF.0000000000003009. http://www.ncbi.nlm.nih.gov/pubmed/33264211
Enlace

Codina H, Vieitez I, Gutierrez-Valencia A, Skouridou V, Martínez C, Patiño L, Botero-Gallego M, Trujillo-Rodríguez M, Serna-Gallego A, Muñoz-Muela E, Bobillo MM, Pérez A, Cabrera-Alvar JJ, Crespo M, O’Sullivan CK, Ruiz-Mateos E, Poveda E. Elevated Anti-SARS-CoV-2 Antibodies and IL-6, IL-8, MIP-1?, Early Predictors of Severe COVID-19. Microorganisms. 2021 Oct;9(11):2259. PMID: 34835384. DOI: 10.3390/microorganisms9112259. http://www.ncbi.nlm.nih.gov/pubmed/34835384
Enlace

Corma-Gómez A, Macías J, Morano L, Rivero A, Téllez F, Ríos MJ, Santos M, Serrano M, Palacios R, Merino D, Real LM, De Los Santos I, Vera-Méndez FJ, Galindo MJ, Pineda JA, RIS-HEP13 and GEHEP 011 Study Groups. Liver Stiffness-Based Strategies Predict Absence of Variceal Bleeding in Cirrhotic Hepatitis C Virus-Infected Patients With and Without Human Immunodeficiency Virus Coinfection After Sustained Virological Response. Clin Infect Dis. 2021;72(5):e96–102. PMID: 33211801. DOI: 10.1093/cid/ciaa1726. http://www.ncbi.nlm.nih.gov/pubmed/33211801
Enlace

Díez C, Del Romero-Raposo J, Mican R, López JC, Blanco JR, Calzado S, Samperiz G, Portilla J, García-Fraile LJ, Gutiérrez F, Gómez-Sirvent JL, Suárez-García I, Amador C, Novella M, Arribas JR, Moreno S, González-García J, Jarrín I, Berenguer J, CoRIS Cohort [Alexandre Pérez; Manuel Crespo; Luis Morano; Celia Miralles; Antonio Ocampo; Guillermo Pousada]. COVID-19 in hospitalized HIV-positive and HIV-negative patients: A matched study. HIV Med. 2021;22(9):867–76. PMID: 34324783. DOI: 10.1111/hiv.13145. http://www.ncbi.nlm.nih.gov/pubmed/34324783
Enlace

Escolà-Vergé L, Cuervo G, de Alarcón A, Sousa D, Barca LV, Fernández-Hidalgo N, IE COVID-19 investigators (MT Pérez-Rodríguez; A Sousa; M Suárez). Impact of the COVID-19 pandemic on the diagnosis, management and prognosis of infective endocarditis. Clin Microbiol Infect. 2021 Apr;27(4):660–4. PMID: 33253944. DOI: 10.1016/j.cmi.2020.11.022. http://www.ncbi.nlm.nih.gov/pubmed/33253944
Enlace

Gonzalez-Serna A, Corma-Gomez A, Tellez F, García-Martin S, Rivero-Juarez A, Frias M, Vera-Méndez FJ, De Los Santos I, Merino D, Morano L, Imaz A, Galera C, Serrano M, Macias J, Pineda JA. Liver stiffness change with HCV cure in HIV-infected patients on non-nucleoside analogues. J Antimicrob Chemother. 2021;76(9):2375–9. PMID: 34021755. DOI: 10.1093/jac/dkab157. http://www.ncbi.nlm.nih.gov/pubmed/34021755
Enlace

Grillo S, Cuervo G, Carratala J, San-Juan R, Aguado JM, Morata L, Gomez-Zorrilla S, López-Contreras J, Gasch O, Gomila-Grange A, Iftimie S, Garcia-Pardo G, Calbo E, Boix-Palop L, Oriol I, Jover-Sáenz A, López-Cortés LE, Euba G, Aguirregabiria M, Garcia-Pais MJ, Gioia F, Paño JR, Pedro-Botet ML, Benítez RM, Pérez-Rodríguez MT, Meije Y, Loeches-Yagüe MB, Horna G, Berbel D, Domínguez MÁ, Padullés A, Cobo S, Hereu P, Videla S, Tebe C, Pallarés N, Miro JM, Pujol M, SAFO study group and the Spanish Network for Research in Infectious Diseases (REIPI). Multicentre, randomised, open-label, phase IV-III study to evaluate the efficacy of cloxacillin plus fosfomycin versus cloxacillin alone in adult patients with methicillin-susceptible Staphylococcus aureus bacteraemia: study protocol for the SAFO trial. BMJ Open. 2021;11(8):e051208. PMID: 34353808. DOI: 10.1136/bmjopen-2021-051208. http://www.ncbi.nlm.nih.gov/pubmed/34353808
Enlace

Gutiérrez-Gutiérrez B, Del Toro MD, Borobia AM, Carcas A, Jarrín I, Yllescas M, Ryan P, Pachón J, Carratalà J, Berenguer J, Arribas JR, Rodríguez-Baño J, REIPI-SEIMC COVID-19 group (M Teresa Pérez-Rodríguez; Alexandre Pérez González) and COVID@HULP groups. Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study. Lancet Infect Dis. 2021 Feb;21(6):783–92. PMID: 33636145. DOI: 10.1016/S1473-3099(21)00019-0. http://www.ncbi.nlm.nih.gov/pubmed/33636145
Enlace

Jaeger H, Overton ET, Richmond G, Rizzardini G, Andrade-Villanueva JF,Mngqibisa R, Hermida AO, Thalme A, Belonosova E, Ajana F, Benn PD, Wang Y, HudsonKJ, Espanol CM, Ford SL, Crauwels H, Margolis DA, Talarico CL, Smith KY, vanEygen V, Van Solingen-Ristea R, Vanveggel S, Spreen WR. Long-acting cabotegravirand rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M),96-week results: a randomised, multicentre, open-label, phase 3b, non-inferioritystudy. Lancet HIV. 2021 Nov;8(11):e679-e689. doi: 10.1016/S2352-3018(21)00185-5.Epub 2021 Oct 11. PubMed PMID: 34648734.

Jiménez de Ory S, Beltrán-Pavez C, Gutiérrez-López M, Santos MDM, Prieto L, Sainz T, Guillen S, Aguilera-Alonso D, Díez C, Bernardino JI, Mellado MJ, Ramos JT, Holguín Á, Navarro M, Paediatric Cohort of the Spanish National AIDS Network (CoRISpe and CoRISpe-FARO) (Celia Miralles; Antonio Ocampo; Guille Pousada). Prevalence of M184V and K65R in proviral DNA from PBMCs in HIV-infected youths with lamivudine/emtricitabine exposure. J Antimicrob Chemother. 2021;76(7):1886–92. PMID: 33734374. DOI: 10.1093/jac/dkab080. http://www.ncbi.nlm.nih.gov/pubmed/33734374
Enlace

Macías J, Téllez F, de Los Santos I, Morano LE, Merino D, Granados R, Vera-Mendez F, González-Serna A, Campo-Moneo E, García-Fraile L, García F, Real LM, Pineda JA, RIS-HEP20 Study and the HEPAVIR and GEHEP Study Groups. Impact of recent drug use on the efficacy of elbasvir/grazoprevir for HCV-infected people on opioid agonist therapy. J Viral Hepat. 2021 Jun;28(6):878–86. PMID: 33721377. DOI: 10.1111/jvh.13496. http://www.ncbi.nlm.nih.gov/pubmed/33721377
Enlace

Marín-Candón A, Rosso-Fernández CM, Bustos de Godoy N, López-Cerero L, Gutiérrez-Gutiérrez B, López-Cortés LE, Barrera Pulido L, Borreguero Borreguero I, León MJ, Merino V, Camean-Fernández M, Retamar P, Salamanca E, Pascual A, Rodriguez-Baño J, ASTARTÉ Study Group [Maria Teresa Pérez Rodríguez; Francisco José Vasallo Vidal; Adrián Sousa Domínguez]. Temocillin versus meropenem for the targeted treatment of bacteraemia due to third-generation cephalosporin-resistant Enterobacterales (ASTARTÉ): protocol for a randomised, pragmatic trial. BMJ Open. 2021;11(9):e049481. PMID: 34580096. DOI: 10.1136/bmjopen-2021-049481. http://www.ncbi.nlm.nih.gov/pubmed/34580096
Enlace

Notararigo S, Varela E, Otal A, Cristobo I, Antolín M, Guarner F, Prieto A, López P. Evaluation of an O2-Substituted (1-3)-?-D-Glucan, Produced by Pediococcus parvulus 2.6, in ex vivo Models of Crohn’s Disease. Front Microbiol. 2021;12:621280. PMID: 33613490. DOI: 10.3389/fmicb.2021.621280. http://www.ncbi.nlm.nih.gov/pubmed/33613490
Enlace

Núñez-Fernández M, Ramos-Hernández C, García-Río F, Torres-Durán M, Nodar-Germiñas A, Tilve-Gómez A, Rodríguez-Fernández P, Valverde-Pérez D, Ruano-Raviña A, Fernández-Villar A. Alterations in Respiratory Function Test Three Months after Hospitalisation for COVID-19 Pneumonia: Value of Determining Nitric Oxide Diffusion. J Clin Med. 2021 May;10(10):2119. PMID: 34068867. DOI: 10.3390/jcm10102119. http://www.ncbi.nlm.nih.gov/pubmed/34068867
Enlace

Perez Elias MJ, Alejos B, Gutierrez MM, Crespo M, De Los Santos Gil I, Ribera E, Galindo MJ, Lozano F, Payeras Cifre A, Boix V, Montero-Alonso M, Sanz J, De La Torre Lima J, Palacios R, De La Fuente Moral S, Martinez E, Codar Study Group. Dynamics of creatinine estimated glomerular filtration rate using one or more antiretrovirals that inhibit creatinine tubular secretion. J Antimicrob Chemother. 2021 Mar;76(4):1046–50. PMID: 33501995. DOI: 10.1093/jac/dkaa547. http://www.ncbi.nlm.nih.gov/pubmed/33501995
Enlace

Pérez-de-Llano L, Romay-Lema EM, Baloira-Villar A, Anchorena C, Torres-Durán ML, Sousa A, Corbacho-Abelaira D, Paz-Ferrin J, Diego-Roza C, Vilariño-Maneiro L, Marcos PJ, Montero-Martínez C, de la Iglesia-Martínez F, Riveiro-Blanco V, Rodríguez-Núñez N, Abal-Arca J, Bustillo-Casado M, Golpe R. COVID-19 pneumonia in Galicia (Spain): Impact of prognostic factors and therapies on mortality and need for mechanical ventilation. PLoS One. 2021;16(6):e0253465. PMID: 34161387. DOI: 10.1371/journal.pone.0253465. http://www.ncbi.nlm.nih.gov/pubmed/34161387
Enlace

Pérez-Rodríguez MT, Sousa A, Moreno-Flores A, Longueira R, Diéguez P, Suárez M, Lima O, Vasallo FJ, Álvarez-Fernández M, Crespo M. The benefits and safety of oral sequential antibiotic therapy in non-complicated and complicated Staphylococcus aureus bacteremia. Int J Infect Dis. 2021 Jan;102:554–60. PMID: 33157291. DOI: 10.1016/j.ijid.2020.10.097. http://www.ncbi.nlm.nih.gov/pubmed/33157291
Enlace

Podzamczer D, Mican R, Tiraboschi J, Portilla J, Domingo P, Llibre JM, RiberaE, Vivancos MJ, Morano L, Masia M, Gomez C, Fanjul F, Payeras A, Inciarte A,Estrada V, Rivero A, Castro A, Bernal E, Vinuesa D, Knobel H, Troya J, Macias J,Montero M, Sanz J, Navarro-Alcaraz A, Caicedo A, Fernandez G, Martinez E, MorenoS. Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide VersusDolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): AMulticenter Randomized Open-Label Study (PReEC/RIS-57). Open Forum Infect Dis.2021 Nov 25;9(3):ofab595. doi: 10.1093/ofid/ofab595. eCollection 2022 Mar. PubMedPMID: 35237700; PubMed Central PMCID: PMC8883591.

Ramos Hernández C, Botana Rial M, Pazos Area LA, Núñez Fernández M, Pérez Fernández S, Rubianes González M, Crespo Casal M, Fernández Villar A. [Lung Ultrasound to Predict Unfavorable Progress in Patients Hospitalized for COVID-19]. Arch Bronconeumol. 2021 Jan;57:47–54. PMID: 34629648. DOI: 10.1016/j.arbres.2020.07.043. http://www.ncbi.nlm.nih.gov/pubmed/34629648
Enlace

Rodríguez OL, Sousa A, Pérez-Rodríguez MT, Martínez-Lamas L, Suárez RL, Martínez CT, Pino CP, Vidal FV, Pérez-Landeiro A, Casal MC. Mortality-related factors in patients with OXA-48 carbapenemase-producing Klebsiella pneumoniae bacteremia. Medicine (Baltimore). 2021 Apr;100(14):e24880. PMID: 33832068. DOI: 10.1097/MD.0000000000024880. http://www.ncbi.nlm.nih.gov/pubmed/33832068
Enlace

Rodríguez-Baño J, Pachón J, Carratalà J, Ryan P, Jarrín I, Yllescas M, Arribas JR, Berenguer J, SAM-COVID Study Group(Ma Teresa Pérez-Rodríguez; Adrián Sousa; Alexandre Pérez-González; Rebeca Longueira; Alejandro Araujo), Fundación SEIMC-GESIDA, Hospital Universitario La Paz, Hospital Universitario Gregorio Marañón, Hospital Infanta Leonor, Complejo Hospitalario Virgen de la Salud, Hospital Universitario Rafael Méndez, Hospital Universitario de Cruces, Hospital de Melilla, Hospital San Eloy de Barakaldo, Hospital Universitario Central de Asturias, Hospital Universitario Puerto Real, Hospital do Salnés, Hospital del Mar, Hospital Virgen de la Arrixaca, Hospital Clínico San Cecilio, Parc Sanitari Sant Joan de Déu, Hospital Josep Trueta, Hospital Dos De Maig – Consorci Sanitari Integral, Hospital Clínico Universitario de Valencia, Complejo Asistencial de Ávila, Hospital Universitario Marqués de Valdecilla, Hospital de Barcelona SCIAS, Hospital Álvaro Cunqueiro, Hospital Universitario Severo Ochoa, Hospital CIMA-
Enlace

Sousa A, Alonso-Herrero A, Pérez-Rodríguez MT, Lima O, Otero A, Suárez M, Longueira R, Martínez-Lamas L, Nodar A, Crespo M. Clinical characteristics, aetiology and mortality/recurrence risk factors of acute cholangitis in patients with and without biliary stent. Enfermedades Infecc y Microbiol Clin (English ed). 2021 Sep;39(9):445–50. PMID: 34736748. DOI: 10.1016/j.eimce.2020.07.011. http://www.ncbi.nlm.nih.gov/pubmed/32980185
Enlace

Suarez-García I, Alejos B, Pérez-Elías M-J, Iribarren J-A, Hernando A, Ramírez M, Tasias M, Pascual M, Jarrin I, Hernando V, CoRIS Cohort [Alexandre Pérez; Manuel Crespo; Luis Morano; Celia Miralles; Antonio Ocampo; Guillermo Pousada]. How do women living with HIV experience menopause? Menopausal symptoms, anxiety and depression according to reproductive age in a multicenter cohort. BMC Womens Health. 2021;21(1):223. PMID: 34049547. DOI: 10.1186/s12905-021-01370-w. http://www.ncbi.nlm.nih.gov/pubmed/34049547
Enlace

Vallejo Camazon N, Mateu L, Cediel G, Escolà-Vergé L, Fernández-Hidalgo N, Gurgui Ferrer M, Perez Rodriguez MT, Cuervo G, Nuñez Aragón R, Llibre C, Sopena N, Quesada MD, Berastegui E, Teis A, Lopez Ayerbe J, Juncà G, Gual F, Ferrer Sistach E, Vivero A, Reynaga E, Hernández Pérez M, Muñoz Guijosa C, Pedro-Botet L, Bayés-Genís A. Long-term antibiotic therapy in patients with surgery-indicated not undergoing surgery infective endocarditis. Cardiol J. 2021;28(4):566–78. PMID: 34031866. DOI: 10.5603/CJ.a2021.0054. http://www.ncbi.nlm.nih.gov/pubmed/34031866
Enlace

Pérez-Rodríguez MT, Sousa-Domínguez A, Pérez-Landeiro A, Martínez-Lamas L. Guía: Profilaxis Quirúrgica. Área Sanitaria de Vigo, revisión 2021

Alejos B, Suárez-García I, Rava M, Bautista-Hernández A, Gutierrez F, Dalmau D, Sagastagoitia I, Rivero A, Moreno S, Jarrín I, CoRIS (Eva Poveda; Alexandre Pérez; Manuel Crespo; Luis Morano; Celia Miralles; Antonio Ocampo; Guillermo Pousada). Effectiveness and safety of first-line antiretroviral regimens in clinical practice: a multicentre cohort study. J Antimicrob Chemother. 2020 Oct;75(10):3004–14. PMID: 32667674. DOI: 10.1093/jac/dkaa246. http://www.ncbi.nlm.nih.gov/pubmed/32667674
Enlace

Berenguer J, Ryan P, Rodríguez-Baño J, Jarrín I, Carratalà J, Pachón J, Yllescas M, Arriba JR, COVID-19@Spain Study Group (Ma Teresa Pérez-Rodríguez; Alexandre Pérez-González), Fundación SEIMC-GESIDA, Hospital General Universitario Gregorio Marañón, Hospital Universitario La Paz, Hospital Infanta Leonor, Complejo Hospitalario Virgen de la Salud, Hospital Universitario Rafael Méndez, Hospital Universitario de Cruces, Hospital de Melilla, Hospital San Eloy de Barakaldo, Hospital Universitario Central de Asturias, Hospital General Universitario de Alicante, Hospital Virgen de la Victoria, Hospital Universitario Puerto Real, EOXI Pontevedra e Salnés, Hospital de Figueres, Hospital Sant Jaume de Calella, Hospital del Mar, Hospital Virgen de la Arrixaca, Hospital de Can Misses, Hospital de Sagunto, Hospital Clínico San Cecilio, Hospital Universitario Príncipe de Asturias, Parc Sanitari Sant Joan de Déu, Hospital Nuestra Señora de Gracia, HC Marbella Internacional Hospital, Hospital La Princesa, Hospital Josep Truet
Enlace

Calò F, Retamar P, Martínez Pérez-Crespo PM, Lanz-García J, Sousa A, Goikoetxea J, Reguera-Iglesias JM, León E, Armiñanzas C, Mantecón MA, Rodríguez-Baño J, López-Cortés LE, PROBAC REIPI/GEIH-SEIMC/SAEI. Catheter-related bloodstream infections: predictive factors for Gram-negative bacteria aetiology and 30 day mortality in a multicentre prospective cohort. J Antimicrob Chemother. 2020;75(10):3056–61. PMID: 32688386. DOI: 10.1093/jac/dkaa262. http://www.ncbi.nlm.nih.gov/pubmed/32688386
Enlace

Casadellà M, Santos JR, Noguera-Julian M, Micán-Rivera R, Domingo P, Antela A, Portilla J, Sanz J, Montero-Alonso M, Navarro J, Masiá M, Valcarce-Pardeiro N, Ocampo A, Pérez-Martínez L, Pasquau J, Vivancos MJ, Imaz A, Carmona-Oyaga P, Muñoz-Medina L, Villar-García J, Barrufet P, Paredes R, INSTINCT Study Group. Primary resistance to integrase strand transfer inhibitors in Spain using ultrasensitive HIV-1 genotyping. J Antimicrob Chemother. 2020;75(12):3517–24. PMID: 32929472. DOI: 10.1093/jac/dkaa349. http://www.ncbi.nlm.nih.gov/pubmed/32929472
Enlace

Corma-Gómez A, Macías J, Lacalle-Remigio JR, Téllez F, Morano L, Rivero A, Serrano M, Ríos MJ, Vera-Méndez FJ, Alados JC, Real LM, Palacios R, Santos IDL, Imatz A, Pineda JA. HIV infection is associated with lower risk of hepatocellular carcinoma after sustained virological response to direct-acting antivirals in hepatitis C infected-patients with advanced fibrosis. Clin Infect Dis. 2020 Aug;(E-PUB) PMID: 32766891. DOI: 10.1093/cid/ciaa1111. http://www.ncbi.nlm.nih.gov/pubmed/32766891
Enlace

Corma-Gómez A, Macías J, Téllez F, Freyre-Carrillo C, Morano L, Rivero-Juárez A, Ríos MJ, Alados JC, Vera-Méndez FJ, Merchante N, Palacios R, Granados R, Merino D, De Los Santos I, Pineda JA. Liver Stiffness at the Time of Sustained Virological Response Predicts the Clinical Outcome in People Living With Human Immunodeficiency Virus and Hepatitis C Virus With Advanced Fibrosis Treated With Direct-acting Antivirals. Clin Infect Dis. 2020 Nov;71(9):2354–62. PMID: 31754695. DOI: 10.1093/cid/ciz1140. http://www.ncbi.nlm.nih.gov/pubmed/31754695
Enlace

Curran A, Rull A, Navarro J, Vidal-González J, Martin-Castillo M, Burgos J, Falcó V, Ribera E, Torrella A, Planas B, Peraire J, Crespo M. Lipidomics Reveals Reduced Inflammatory Lipid Species and Storage Lipids after Switching from EFV/FTC/TDF to RPV/FTC/TDF: A Randomized Open-Label Trial. J Clin Med. 2020 Apr;9(5) PMID: 32344934. DOI: 10.3390/jcm9051246. http://www.ncbi.nlm.nih.gov/pubmed/32344934
Enlace

Del Amo J, Polo R, Moreno S, Díaz A, Martínez E, Arribas JR, Jarrín I, Hernán MA, The Spanish HIV/COVID-19 Collaboration (A Ocampo; G Pousada). Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy?: A Cohort Study. Ann Intern Med. 2020;173(7):536–41. PMID: 32589451. DOI: 10.7326/M20-3689. http://www.ncbi.nlm.nih.gov/pubmed/32589451
Enlace

Escolà-Vergé L, Peghin M, Givone F, Pérez-Rodríguez MT, Suárez-Varela M, Meije Y, Abelenda G, Almirante B, Fernández-Hidalgo N. Prevalence of colorectal disease in Enterococcus faecalis infective endocarditis: results of an observational multicenter study. Rev Esp Cardiol (Engl Ed). 2020 Sep;73(9):711–7. PMID: 31444092. DOI: 10.1016/j.rec.2019.07.007. http://www.ncbi.nlm.nih.gov/pubmed/31444092
Enlace

Lago-Docampo M, Tenorio J, Hernández-González I, Pérez-Olivares C, Escribano-Subías P, Pousada G, Baloira A, Arenas M, Lapunzina P, Valverde D. Characterization of rare ABCC8 variants identified in Spanish pulmonary arterial hypertension patients. Sci Rep. 2020;10(1):15135. PMID: 32934261. DOI: 10.1038/s41598-020-72089-1. http://www.ncbi.nlm.nih.gov/pubmed/32934261
Enlace

Martinez E, Negredo E, Knobel H, Ocampo A, Sanz J, Garcia-Fraile L, Martin-Carbonero L, Lozano F, Gonzalez-Domenech CM, Gutierrez M, Montero M, Boix V, Payeras A, Torralba M, Gonzalez-Cordon A, Moreno A, Alejos B, Perez-Elias MJ, GeSIDA 9316 CODAR Study Group. Factors associated with the number of drugs in darunavir/cobicistat regimens. J Antimicrob Chemother. 2020 Jan;75(1):208–14. PMID: 31586414. DOI: 10.1093/jac/dkz399. http://www.ncbi.nlm.nih.gov/pubmed/31586414
Enlace

Ocampo Cancelas A, Diniz Freitas M, Perez Gonzalez A, Perez Castro S, CarballoFernandez R, Iribarren Diaz M, Ocampo Hermida A, Diz Dios P, Limeres Posse J.Concordance between oral and anal human papillomavirus infection in HIV-infectedmen who have sex with men. Oral Dis. 2020 Jan;26(1):224-227. doi:10.1111/odi.13197. Epub 2019 Nov 6. No abstract available. PubMed PMID: 31529737.

Pineda JA, Climent B, García F, García Deltoro M, Granados R, Gómez F, Macías J, Mena Á, Merchante N, Ochoa E, Roncero C, Ruiz JJ, Téllez F, Morano L. Executive summary: Consensus document of GEHEP of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), along with SOCIDROGALCOHOL, SEPD and SOMAPA on hepatitis C virus infection management in drug users. Enferm Infecc Microbiol Clin. 2020 Mar;38(3):127–31. PMID: 30415884. DOI: 10.1016/j.eimc.2018.09.006. http://www.ncbi.nlm.nih.gov/pubmed/30415884
Enlace

Rivero-Juárez A, Aguilera A, Avellón A, García-Deltoro M, García F, Gortazar C, Granados R, Macías J, Merchante N, Oteo JA, Pérez-Gracia MT, Pineda JA, Rivero A, Rodriguez-Lazaro D, Téllez F, Morano-Amado LE, Grupo redactor de GeHEP SEIMC. Executive summary: Consensus document of the diagnosis, management and prevention of infection with the hepatitis E virus: Study Group for Viral Hepatitis (GEHEP) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). Enferm Infecc Microbiol Clin. 2020 Jan;38(1):28–32. PMID: 30072282. DOI: 10.1016/j.eimc.2018.06.014. http://www.ncbi.nlm.nih.gov/pubmed/30072282
Enlace

Serrano-Villar S, Martínez-Sanz J, Ron R, Talavera-Rodríguez A, Fernández-Felix BM, Herrera S, Muriel A, Fanjul F, Portilla J, Muñoz J, Amador C, de Zárraga MA, Vivancos MJ, Moreno S, Spanish HIV Research Network (CoRIS) (Eva Poveda; Alexandre Pérez; Manuel Crespo; Luis Morano; Celia Miralles; Antonio Ocampo; Guillermo Pousada). Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study. lancet HIV. 2020;7(8):e565–73. PMID: 32763219. DOI: 10.1016/S2352-3018(20)30202-2. http://www.ncbi.nlm.nih.gov/pubmed/32763219
Enlace

Suárez-García I, Moreno C, Ruiz-Algueró M, Pérez-Elías MJ, Navarro M, Díez Martínez M, Viciana P, Pérez-Martínez L, Górgolas M, Amador C, de Zárraga MA, Jarrín I, Cohort of the Spanish HIV/ADS Research Network (CoRIS) (Eva Poveda; Alexandre Pérez; Manuel Crespo; Luis Morano; Celia Miralles; Antonio Ocampo; Guillermo Pousada). Effectiveness of the combination elvitegravir/cobicistat/tenofovir/emtricitabine (EVG/COB/TFV/FTC) plus darunavir among treatment-experienced patients in clinical practice: a multicentre cohort study. AIDS Res Ther. 2020;17(1):45. PMID: 32690099. DOI: 10.1186/s12981-020-00302-2. http://www.ncbi.nlm.nih.gov/pubmed/32690099
Enlace

Suárez-García I, Ruiz-Algueró M, García Yubero C, Moreno C, Belza MJ, Estébanez M, de Los Santos I, Masiá M, Samperiz Abad G, Muñoz Sánchez J, Omar M, Jarrín I, Cohort of the Spanish HIV/AIDS Research Network (CoRIS) (Eva Poveda; Alexandre Pérez; Manuel Crespo; Luis Morano; Celia Miralles; Antonio Ocampo; Guillermo Pousada). Physicians’ opinions on generic antiretroviral drugs and single-tablet regimen de-simplification for the treatment of HIV infection: a multicentre survey in Spain. J Antimicrob Chemother. 2020;75(2):466–72. PMID: 31665404. DOI: 10.1093/jac/dkz439. http://www.ncbi.nlm.nih.gov/pubmed/31665404
Enlace

Ocampo-Hermida A, Pérez A. Caso 8. In: Pérez Domínguez L, Facal Álvarez C (eds.). Infección por VIH en Galicia A propósito de nuestros casos clínicos. Grupo Aula Médica, S.L; 2020. p. 37–42. ISBN: 978-8478856701. https://books.google.es/books/about/Infección_por_VIH_en_Galicia.html?id=RQODzgEACAAJ&redir_esc=y
Enlace

Val N.; Suarez M.; Longueira R. La afectación neurológica en la primoinfección por VIH. En: Ocampo-Hermida A, Pérez A. Caso 8. In: Pérez Domínguez L, Facal Álvarez C (eds.). Infección por VIH en Galicia A propósito de nuestros casos clínicos. Grupo Aula Médica, S.L; 2020. p. 37–42. ISBN: 978-8478856701. https://books.google.es/books/about/Infección_por_VIH_en_Galicia.html?id=RQODzgEACAAJ&redir_esc=y
Enlace

AIDS Study Group (GeSIDA) of the Spanish Society of Infectious Diseases and Clinical Microbiology [Eva Poveda; Antonio Ocampo]. Executive summary of the GeSIDA consensus document on control and monitoring of HIV-infected patients. Enferm Infecc Microbiol Clin. 2019 May;37(7):467–75. PMID: 29793873. DOI: 10.1016/j.eimc.2018.03.011. http://www.ncbi.nlm.nih.gov/pubmed/29793873
Enlace

Cachay ER, Mena A, Morano L, Benitez L, Maida I, Ballard C, Hill L, Torriani F, Castro A, Dore E, Castro S, de Mendoza Fernández C, Soriano V, Mathews WC, HCV-TREN Cohort. Predictors of Hepatitis C Treatment Failure After Using Direct-Acting Antivirals in People Living With Human Immunodeficiency Virus. Open forum Infect Dis. 2019 Mar;6(3):ofz070. PMID: 30949524. DOI: 10.1093/ofid/ofz070. http://www.ncbi.nlm.nih.gov/pubmed/30949524
Enlace

Corma-Gómez A, Macías J, Merino Muñoz D, Téllez F, Granados R, Morano LE, De Los Santos Gil I, Vera-Méndez FJ, Collado A, Palacios R, Pineda JA. Higher relapse rate among HIV/HCV-coinfected patients receiving sofosbuvir/ledipasvir for 8 vs 12 weeks. J Infect. 2019;79(1):30–5. PMID: 31100364. DOI: 10.1016/j.jinf.2019.05.005. http://www.ncbi.nlm.nih.gov/pubmed/31100364
Enlace

Corma-Gómez A, Morano L, Téllez F, Rivero-Juárez A, Real LM, Alados JC, Ríos-Villegas MJ, Vera-Méndez FJ, Muñoz RP, Geijo P, Macías J, Pineda JA, RIS-HEP13 and GEHEP 011 study groups. HIV infection does not increase the risk of liver complications in hepatitis C virus-infected patient with advanced fibrosis, after sustained virological response with direct-acting antivirals. AIDS. 2019;33(7):1167–74. PMID: 30845068. DOI: 10.1097/QAD.0000000000002186. http://www.ncbi.nlm.nih.gov/pubmed/30845068
Enlace

Corredoira J, Miguez E, Mateo LM, Fernández-Rodriguez R, García-Rodriguez JF, Peréz-Gonzalez A, Sanjurjo A, Pulian M V, Rabuñal R, GESBOGA. Correlation between Streptococcus bovis bacteremia and density of cows in Galicia, northwest of Spain. Infection. 2019 Jun;47(3):399–407. PMID: 30498902. DOI: 10.1007/s15010-018-1254-x. http://www.ncbi.nlm.nih.gov/pubmed/30498902
Enlace

Cózar A, Ramos-Martínez A, Merino E, Martínez-García C, Shaw E, Marrodán T, Calbo E, Bereciartúa E, Sánchez-Muñoz LA, Salavert M, Pérez-Rodríguez MT, García D, Bravo-Ferrer JM, Gálvez-Acebal J, Henríquez C, Cuquet J, Gil-Campesino H, Torres L, Sánchez-Porto A, Royuela A, Cobo J, Study group. High delayed mortality after the first episode of Clostridium difficile infection. Anaerobe. 2019 Jun;57:93–8. PMID: 30959165. DOI: 10.1016/j.anaerobe.2019.04.004. http://www.ncbi.nlm.nih.gov/pubmed/30959165
Enlace

De Mendoza C, Pirón M, Gonzalez R, Jiménez A, Caballero E, Roc L, Benito R, Ramos JM, Soriano V, HTLV Spanish Study Group (S Pérez; L Morano). Clinical Presentation of Individuals With Human T-Cell Leukemia Virus Type-1 Infection in Spain. Open forum Infect Dis. 2019 Feb;6(2):ofz036. PMID: 30815504. DOI: 10.1093/ofid/ofz036. http://www.ncbi.nlm.nih.gov/pubmed/30815504
Enlace

Delgado E, Benito S, Montero V, Cuevas MT, Fernández-García A, Sánchez-Martínez M, García-Bodas E, Díez-Fuertes F, Gil H, Cañada J, Carrera C, Martínez-López J, Sintes M, Pérez-Álvarez L, Thomson MM, Spanish Group for the Study of New HIV Diagnoses. Diverse Large HIV-1 Non-subtype B Clusters Are Spreading Among Men Who Have Sex With Men in Spain. Front Microbiol. 2019;10:655. PMID: 31001231. DOI: 10.3389/fmicb.2019.00655. http://www.ncbi.nlm.nih.gov/pubmed/31001231
Enlace

Guillén Y, Noguera-Julian M, Rivera J, Casadellà M, Zevin AS, Rocafort M, Parera M, Rodríguez C, Arumí M, Carrillo J, Mothe B, Estany C, Coll J, Bravo I, Herrero C, Saz J, Sirera G, Torrella A, Navarro J, Crespo M, Negredo E, Brander C, Blanco J, Calle ML, Klatt NR, Clotet B, Paredes R. Low nadir CD4+ T-cell counts predict gut dysbiosis in HIV-1 infection. Mucosal Immunol. 2019 Aug;12(1):232–46. PMID: 30171206. DOI: 10.1038/s41385-018-0083-7. http://www.ncbi.nlm.nih.gov/pubmed/30171206
Enlace

Habib G, Erba PA, Iung B, Donal E, Cosyns B, Laroche C, Popescu BA, Prendergast B, Tornos P, Sadeghpour A, Oliver L, Vaskelyte J-J, Sow R, Axler O, Maggioni AP, Lancellotti P, EURO-ENDO Investigators (F. Calvo Iglesias; E. Blanco-Gonzalez; M. Bravo Amaro; E. LopezRodriguez; J. Lugo Adan; A.N. Germinas; P. Pazos-Lopez; M. Pereira Loureiro; M.T. Perez; S. Raposeiras-Roubin; S. Rasheed Yas; M-M. Suarez-Varela; F. Vasallo Vidal). Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study. Eur Heart J. 2019;40(39):3222–32. PMID: 31504413. DOI: 10.1093/eurheartj/ehz620. http://www.ncbi.nlm.nih.gov/pubmed/31504413
Enlace

Habib G, Lancellotti P, Erba P-A, Sadeghpour A, Meshaal M, Sambola A, Furnaz S, Citro R, Ternacle J, Donal E, Cosyns B, Popescu B, Iung B, Prendergast B, Laroche C, Tornos P, Pazdernik M, Maggioni A, Gale CP, EURO-ENDO Investigators (F. Calvo Iglesias; E. Blanco-Gonzalez; M. Bravo Amaro; E. LopezRodriguez; J. Lugo Adan; A.N. Germinas; P. Pazos-Lopez; M. Pereira Loureiro; M.T. Perez; S. Raposeiras-Roubin; S. Rasheed Yas; M-M. Suarez-Varela; F. Vasallo Vidal). The ESC-EORP EURO-ENDO (European Infective Endocarditis) registry. Eur Hear journal Qual care Clin outcomes. 2019;5(3):202–7. PMID: 30957862. DOI: 10.1093/ehjqcco/qcz018. http://www.ncbi.nlm.nih.gov/pubmed/30957862
Enlace

Londoño M-C, Riveiro-Barciela M, Ahumada A, Muñoz-Gómez R, Roget M, Devesa-Medina MJ, Serra MÁ, Navascués CA, Baliellas C, Aldamiz-Echevarría T, Gutiérrez ML, Polo-Lorduy B, Carmona I, Benlloch S, Bonet L, García-Samaniego J, Jiménez-Pérez M, Morán-Sánchez S, Castro Á, Delgado M, Gea-Rodríguez F, Martín-Granizo I, Montes ML, Morano L, Castaño MA, de Los Santos I, Laguno M, Losa JE, Montero-Alonso M, Rivero A, de Álvaro C, Manzanares A, Mallolas J, Barril G, González-Parra E, García-Buey L. Effectiveness, safety/tolerability of OBV/PTV/r ± DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease (CKD) stage IIIb-V and dialysis in Spanish clinical practice – Vie-KinD study. PLoS One. 2019;14(9):e0221567. PMID: 31550267. DOI: 10.1371/journal.pone.0221567. http://www.ncbi.nlm.nih.gov/pubmed/31550267
Enlace

López-Isac E, Acosta-Herrera M, Kerick M, Assassi S, Satpathy AT, Granja J, Mumbach MR, Beretta L, Simeón CP, Carreira P, Ortego-Centeno N, Castellvi I, Bossini-Castillo L, Carmona FD, Orozco G, Hunzelmann N, Distler JHW, Franke A, Lunardi C, Moroncini G, Gabrielli A, de Vries-Bouwstra J, Wijmenga C, Koeleman BPC, Nordin A, Padyukov L, Hoffmann-Vold A-M, Lie B, European Scleroderma Group†, Proudman S, Stevens W, Nikpour M, Australian Scleroderma Interest Group (ASIG), Vyse T, Herrick AL, Worthington J, Denton CP, Allanore Y, Brown MA, Radstake TRDJ, Fonseca C, Chang HY, Mayes MD, Martin J, Sousa) ESG (Adrián. GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways. Nat Commun. 2019;10(1):4955. PMID: 31672989. DOI: 10.1038/s41467-019-12760-y. http://www.ncbi.nlm.nih.gov/pubmed/31672989
Enlace

Macías J, Granados R, Téllez F, Merino D, Pérez M, Morano LE, Palacios R, Paniagua M, Frías M, Merchante N, Pineda JA, HEPAVIR GEHEP R-H study groups. Similar recovery of liver function after response to all-oral HCV therapy in patients with cirrhosis with and without HIV coinfection. J Viral Hepat. 2019 Jan;26(1):16–24. PMID: 30141222. DOI: 10.1111/jvh.12990. http://www.ncbi.nlm.nih.gov/pubmed/30141222
Enlace

Macías J, Morano LE, Téllez F, Granados R, Rivero-Juárez A, Palacios R, Ríos M, Merino D, Pérez-Pérez M, Collado A, Figueruela B, Morano A, Freyre-Carrillo C, Martín JM, Rivero A, García F, Pineda JA, HEPAVIR group from the Sociedad Andaluza de Enfermedades Infecciosas (SAEI) and the GEHEP group from the Sociedad Española de Enfermedades Infecciosas y Microbiología (SEIMC). Response to direct-acting antiviral therapy among ongoing drug users and people receiving opioid substitution therapy. J Hepatol. 2019;71(1):45–51. PMID: 30853642. DOI: 10.1016/j.jhep.2019.02.018. http://www.ncbi.nlm.nih.gov/pubmed/30853642
Enlace

Macías J, Téllez F, Rivero-Juárez A, Palacios R, Morano LE, Merino D, Collado A, García-Fraile L, Omar M, Pineda JA, the HEPAVIR G and R-H study groups. Early emergence of opportunistic infections after starting direct-acting antiviral drugs in HIV/HCV-coinfected patients. J Viral Hepat. 2019 Sep;26(1):48–54. PMID: 30199593. DOI: 10.1111/jvh.13003. http://www.ncbi.nlm.nih.gov/pubmed/30199593
Enlace

Manuel Sousa J, Vergara M, Pulido F, Sánchez Antolín G, Hijona L, Carnicer F, Rincón D, Salmerón J, Mateos-Muñoz B, Jou A, Polo-Lorduy B, Rubín Á, Escarda A, Aguilar P, Aldámiz-Echevarría T, García-Buey L, Carrión JA, Hernández-Guerra M, Chimeno-Hernández S, Espinosa N, Morillas RM, Andrade RJ, Delgado M, Gallego A, Magaz M, Moreno-Planas JM, Estébanez Á, Rico M, Menéndez F, Sampedro B, Morano L, Izquierdo S, Zozaya JM, Rodríguez M, Morán-Sánchez S, Lorente S, Martín-Granizo I, Von-Wichmann MÁ, Delgado M, Manzanares A. Real-world evidence of the effectiveness of ombitasvir-paritaprevir/r ± dasabuvir ± ribavirin in patients monoinfected with chronic hepatitis C or coinfected with human immunodeficiency virus-1 in Spain. PLoS One. 2019;14(11):e0225061. PMID: 31714950. DOI: 10.1371/journal.pone.0225061. http://www.ncbi.nlm.nih.gov/pubmed/31714950
Enlace

Marra E, Lin C, Clifford GM. Type-Specific Anal Human Papillomavirus Prevalence Among Men, According to Sexual Preference and HIV Status: A Systematic Literature Review and Meta-Analysis. J Infect Dis. 2019;219(4):590–8. PMID: 30239749. DOI: 10.1093/infdis/jiy556. http://www.ncbi.nlm.nih.gov/pubmed/30239749
Enlace

Morón-López S, Navarro J, Jimenez M, Rutsaert S, Urrea V, Puertas MC, Torrella A, De Clercq L, Ribas BP, Gálvez C, Salgado M, Vandekerckhove L, Blanco J, Crespo M, Martinez-Picado J. Switching From a Protease Inhibitor-based Regimen to a Dolutegravir-based Regimen: A Randomized Clinical Trial to Determine the Effect on Peripheral Blood and Ileum Biopsies From Antiretroviral Therapy-suppressed Human Immunodeficiency Virus-infected Indi. Clin Infect Dis. 2019;69(8):1320–8. PMID: 30590412. DOI: 10.1093/cid/ciy1095. http://www.ncbi.nlm.nih.gov/pubmed/30590412
Enlace

Ocampo Hermida A, Longueira Suárez R, Castro Iglesias Á, Asorey Carballeira Á, De la Fuente Aguado J. Despistaje de la infección por el virus de inmunodeficiencia humana en Atención Primaria mediante indicadores de sospecha: estudio DIVAPIS. Galicia Clínica. 2019 Oct;80(4):70. DOI: 10.22546/54/1699. http://doi.org/10.22546/54/1699
Enlace

Pérez Elías MJ, Alejos B, Vivancos MJ, Ribera E, Galindo MJ, Vilanova-Trillo L, García-Fraile Fraile LJ, de La Fuente Moral S, Garcia De Lomas J, Lozano F, Mateo García MG, Tasias Pitarch M, Diez Martinez M, Rojas J, Raya-Cruz M, Sepúlveda MA, Troya J, Del Campo S, Martinez E, CODAR study group. Outcomes by sex following treatment initiation with darunavir/cobicistat in a large Spanish cohort of the CODAR study (GeSIDA 9316). J Antimicrob Chemother. 2019;74(10):3044–8. PMID: 31236601. DOI: 10.1093/jac/dkz254. http://www.ncbi.nlm.nih.gov/pubmed/31236601
Enlace

Pérez-Matute P, Íñiguez M, Villanueva-Millán MJ, Recio-Fernández E, Vázquez AM, Sánchez SC, Morano LE, Oteo JA. Short-term effects of direct-acting antiviral agents on inflammation and gut microbiota in hepatitis C-infected patients. Eur J Intern Med. 2019 Sep;67:47–58. PMID: 31221551. DOI: 10.1016/j.ejim.2019.06.005. http://www.ncbi.nlm.nih.gov/pubmed/31221551
Enlace

Pérez-Rodríguez MT, Sousa A, López-Cortés LE, Martínez-Lamas L, Val N, Baroja A, Nodar A, Vasallo F, Álvarez-Fernández M, Crespo M, Rodríguez-Baño J. Moving beyond unsolicited consultation: additional impact of a structured intervention on mortality in Staphylococcus aureus bacteraemia. J Antimicrob Chemother. 2019;74(4):1101–7. PMID: 30689894. DOI: 10.1093/jac/dky556. http://www.ncbi.nlm.nih.gov/pubmed/30689894
Enlace

Raben D, Sullivan AK, Mocroft A, Kutsyna G, Hadžiosmanovi? V, Vassilenko A, Chkhartisvili N, Mitsura V, Pedersen C, Anderson J, Begovac J, Bak Dragsted U, Bertisch B, Grzeszczuk A, Minton J, Necsoi VC, Kitchen M, Ajana F, Sokhan A, Comi L, Farazmand P, Pesut D, De Wit S, Gatell JM, Gazzard B, d’Arminio Monforte A, Rockstroh JK, Yazdanpanah Y, Champenois K, Jakobsen ML, Lundgren JD, HIDES Study Group (Antonio Ocampo). Improving the evidence for indicator condition guided HIV testing in Europe: Results from the HIDES II Study – 2012 – 2015. PLoS One. 2019;14(8):e0220108. PMID: 31408476. DOI: 10.1371/journal.pone.0220108. http://www.ncbi.nlm.nih.gov/pubmed/31408476
Enlace

Requena S, Caballero E, Lozano AB, Ríos-Villegas MJ, Benito R, Rojo S, Cabezas T, Macià MD, Nieto MDC, Soriano V, de Mendoza C, Spanish HIV-2 Study Group. Treatment outcome in dually HIV-1 and HIV-2 coinfected patients living in Spain. AIDS. 2019;33(14):2167–72. PMID: 31373918. DOI: 10.1097/QAD.0000000000002338. http://www.ncbi.nlm.nih.gov/pubmed/31373918
Enlace

Rizzardini G, Gori A, Miralles C, Olalla J, Molina J-M, Raffi F, Kumar P, Antinori A, Ramgopal M, Stellbrink H-J, Das M, Chu H, Ram R, Garner W, Shao Y, Chuck SK, Piontkowsky D, Haubrich RH. Randomized study evaluating the efficacy and safety of switching from an an abacavir/lamivudine-based regimen to an elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide single-tablet regimen. AIDS. 2019;33(10):1583–93. PMID: 31305329. DOI: 10.1097/QAD.0000000000002244. http://www.ncbi.nlm.nih.gov/pubmed/31305329
Enlace

Rosás-Umbert M, Llano A, Bellido R, Olvera A, Ruiz-Riol M, Rocafort M, Fernández MA, Cobarsi P, Crespo M, Dorrell L, Del Romero J, Alcami J, Paredes R, Brander C, Mothe B. Mechanisms of Abrupt Loss of Virus Control in a Cohort of Previous HIV Controllers. J Virol. 2019;93(4) PMID: 30487276. DOI: 10.1128/JVI.01436-18. http://www.ncbi.nlm.nih.gov/pubmed/30487276
Enlace

Sousa A, Pérez-Rodríguez MT, Suarez M, Val N, Martínez-Lamas L, Nodar A, Crespo M. Validation of a clinical decision tree to predict if a patient has a bacteraemia due to a ?-lactamase producing organism. Infect Dis (London, England). 2019 Jan;51(1):32–7. PMID: 30371118. DOI: 10.1080/23744235.2018.1508883. http://www.ncbi.nlm.nih.gov/pubmed/30371118
Enlace

Sousa A, Pérez-Rodríguez MT, Suárez M, Val N, Martínez-Lamas L, Nodar A, Longueira R, Crespo M. Short- versus long-course therapy in gram-negative bacilli bloodstream infections. Eur J Clin Microbiol Infect Dis. 2019 May;38(5):851–7. PMID: 30680566. DOI: 10.1007/s10096-019-03467-5. http://www.ncbi.nlm.nih.gov/pubmed/30680566
Enlace

Vázquez-Morón S, Berenguer J, González-García J, Jiménez-Sousa MÁ, Canorea I, Guardiola JM, Crespo M, Quereda C, Sanz J, Carrero A, Hontañón V, Avellón A, Resino S. Prevalence of hepatitis E infection in HIV/HCV-coinfected patients in Spain (2012-2014). Sci Rep. 2019;9(1):1143. PMID: 30718554. DOI: 10.1038/s41598-018-37328-6. http://www.ncbi.nlm.nih.gov/pubmed/30718554
Enlace

AIDS Study Group (GESIDA) of the Spanish Society of Infectious Diseases and Clinical Microbiology and the National AIDS Plan [Manuel Crespo; Eva Poveda]. Executive summary of the GESIDA/National AIDS Plan Consensus Document on Antiretroviral Therapy in Adults Infected by the Human Immunodeficiency Virus (Updated January 2017). Enferm Infecc Microbiol Clin. 2018 Aug;36(7):435–45. PMID: 28579016. DOI: 10.1016/j.eimc.2017.04.001. http://www.ncbi.nlm.nih.gov/pubmed/28579016
Enlace

Berenguer J, Jarrín I, Pérez-Latorre L, Hontañón V, Vivancos MJ, Navarro J, Téllez MJ, Guardiola JM, Iribarren JA, Rivero-Juárez A, Márquez M, Artero A, Morano L, Santos I, Moreno J, Fariñas MC, Galindo MJ, Hernando MA, Montero M, Cifuentes C, Domingo P, Sanz J, Domíngez L, Ferrero OL, De la Fuente B, Rodríguez C, Reus S, Hernández-Quero J, Gaspar G, Pérez-Martínez L, García C, Force L, Veloso S, Losa JE, Vilaró J, Bernal E, Arponen S, Ortí AJ, Chocarro Á, Teira R, Alonso G, Silvariño R, Vegas A, Geijo P, Bisbe J, Esteban H, González-García J, GeSIDA 8514 Study Group. Human Immunodeficiency Virus/Hepatits C Virus Coinfection in Spain: Elimination Is Feasible, but the Burden of Residual Cirrhosis Will Be Significant. Open forum Infect Dis. 2018 Jan;5(1):ofx258. PMID: 29354658. DOI: 10.1093/ofid/ofx258. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767960/pdf/ofx258.pdf
Enlace

Carrillo J, Negredo E, Puig J, Molinos-Albert LM, Rodríguez de la Concepción ML, Curriu M, Massanella M, Navarro J, Crespo M, Viñets E, Millá F, Clotet B, Blanco J. Memory B cell dysregulation in HIV-1-infected individuals. AIDS. 2018 Jan;32(2):149–60. PMID: 29112067. DOI: 10.1097/QAD.0000000000001686. http://www.ncbi.nlm.nih.gov/pubmed/29112067
Enlace

Cobo J, Merino E, Martínez C, Cózar-Llistó A, Shaw E, Marrodán T, Calbo E, Bereciartúa E, Sánchez-Muñoz LA, Salavert M, Pérez-Rodríguez MT, García-Rosado D, Bravo-Ferrer JM, Gálvez-Acebal J, Henríquez-Camacho C, Cuquet J, Pino-Calm B, Torres L, Sánchez-Porto A, Fernández-Félix BM, Nosocomial Infection Study Group. Prediction of recurrent clostridium difficile infection at the bedside: the GEIH-CDI score. Int J Antimicrob Agents. 2018 Mar;51(3):393–8. PMID: 28939450. DOI: 10.1016/j.ijantimicag.2017.09.010. http://www.ncbi.nlm.nih.gov/pubmed/28939450
Enlace

Esteban R, Pineda JA, Calleja JL, Casado M, Rodríguez M, Turnes J, Morano Amado LE, Morillas RM, Forns X, Pascasio Acevedo JM, Andrade RJ, Rivero A, Carrión JA, Lens S, Riveiro-Barciela M, McNabb B, Zhang G, Camus G, Stamm LM, Brainard DM, Subramanian GM, Buti M. Efficacy of Sofosbuvir and Velpatasvir, With and Without Ribavirin, in Patients With Hepatitis C Virus Genotype 3 Infection and Cirrhosis. Gastroenterology. 2018 Oct;155(4):1120-1127.e4. PMID: 29958855. DOI: 10.1053/j.gastro.2018.06.042. http://www.ncbi.nlm.nih.gov/pubmed/29958855
Enlace

Martinez Lamas L, Pérez-Rodríguez MT, Alvarez Ramos I, Bouza Soage ME, Figueroa Lamas MP, Alvarez Fernandez M, Martínez Lamas L, Pérez Rodríguez MT, Álvarez Ramos I, Bouza Soage ME, Figueroa Lamas MP, Álvarez Fernández M. Role of Pneumocystis jirovecii in patients with different pulmonary underlying condition using a nested-PCR. Rev Esp Quimioter. 2018 Aug;31(4):336–43. PMID: 29956896. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172691/pdf/revespquimioter-31-336.pdf
Enlace

Medrano LM, Garcia-Broncano P, Berenguer J, González-García J, Jiménez-Sousa MÁ, Guardiola JM, Crespo M, Quereda C, Sanz J, Canorea I, Carrero A, Hontañón V, Muñoz-Fernández MÁ, Resino S, GESIDA 3603b Study Group. Elevated liver stiffness is linked to increased biomarkers of inflammation and immune activation in HIV/hepatitis C virus-coinfected patients. AIDS. 2018 Jun;32(9):1095–105. PMID: 29438197. DOI: 10.1097/QAD.0000000000001787. http://www.ncbi.nlm.nih.gov/pubmed/29438197
Enlace

Ocampo A, Domingo P, Fernández P, Diz J, Barberá JR, Sepúlveda MA, Salgado X, Rodriguez M, Santos J, Yzusqui M, Mayorga MI, Lorenzo JF, Bahamonde A, Bachiller P, Martínez E, Rozas N, Torres C, Muñoz A, Casado A, Podzamczer D. Lipid changes and tolerability in a cohort of adult HIV-infected patients who switched to rilpivirine/emtricitabine/tenofovir due to intolerance to previous combination ART: the PRO-STR study. J Antimicrob Chemother. 2018 Aug;73(8):2171–6. PMID: 29788066. DOI: 10.1093/jac/dky175. http://www.ncbi.nlm.nih.gov/pubmed/29788066
Enlace

Papst L, Beovi? B, Pulcini C, Durante-Mangoni E, Rodríguez-Baño J, Kaye KS, Daikos GL, Raka L, Paul M, ESGAP, ESGBIS E and the C treatment survey study group (Pérez RM. Antibiotic treatment of infections caused by carbapenem-resistant Gram-negative bacilli: an international ESCMID cross-sectional survey among infectious diseases specialists practicing in large hospitals. Clin Microbiol Infect. 2018 Oct;24(10):1070–6. PMID: 29410094. DOI: 10.1016/j.cmi.2018.01.015. http://www.ncbi.nlm.nih.gov/pubmed/29410094
Enlace

Pérez-Valero I, Pasquau J, Rubio R, Rivero A, Santos J, Sanz J, Mariño A, Crespo M, Hernández-Quero J, Iribarren JA, Gutiérrez F, Terrón A, Esteban H, Pérez-Molina JA, GESIDA 7011 Study Group members (Miralles C; Ocampo A). Neurocognitive safety after 96 weeks on dual therapy with atazanavir/ritonavir plus lamivudine: results of the neurocognitive substudy of the SALT randomized clinical trial. J Antimicrob Chemother. 2018 Sep;73(9):2444–51. PMID: 29897573. DOI: 10.1093/jac/dky212. http://www.ncbi.nlm.nih.gov/pubmed/29897573
Enlace

Piera Rojo G, Fachal Bermudez C, Morano Amado L. Hypochromic skin lesions in Brazilian patient. Med Clin (Barc). 2018 Sep;151(6):e35. PMID: 29276011. DOI: 10.1016/j.medcli.2017.10.040. http://www.ncbi.nlm.nih.gov/pubmed/29276011
Enlace

Pousada G, Lago-Docampo M, Prado S, Varela-Calviño R, Mantiñán B, Valverde D. Functional assessment of the BMPR2 gene in lymphoblastoid cell lines from Graves’ disease patients. J Cell Mol Med. 2018 Mar;22(3):1538–47. PMID: 29266775. DOI: 10.1111/jcmm.13425. http://www.ncbi.nlm.nih.gov/pubmed/29266775
Enlace

Poveda E, Crespo M. Hot News: Impact of Low-level Viremia on Treatment Outcomes During ART – Is it Time to Revise the Definition of Virological Failure? AIDS Rev. 2018;20(1):71–2. PMID: 29628513. http://www.ncbi.nlm.nih.gov/pubmed/29628513
Enlace

Real LM, Macías J, Pérez AB, Merino D, Granados R, Morano L, Delgado M, Ríos MJ, Galera C, Deltoro MG, Merchante N, García F, Pineda JA. Baseline resistance-guided therapy does not enhance the response to interferon-free treatment of HCV infection in real life. Sci Rep. 2018 Oct;8(1):14905. PMID: 30297726. DOI: 10.1038/s41598-018-33367-1. http://www.ncbi.nlm.nih.gov/pubmed/30297726
Enlace

Sousa A, Pérez-Rodríguez MT, Nodar A, Martínez-Lamas L, Vasallo FJ, Álvarez-Fernández M, Crespo M. Clinical and microbiological characteristics of unusual manifestations of invasive pneumococcal disease. Enferm Infecc Microbiol Clin. 2018 May;36(5):284–9. PMID: 28648390. DOI: 10.1016/j.eimc.2017.05.003. http://www.ncbi.nlm.nih.gov/pubmed/28648390
Enlace

Sousa A, Pérez-Rodríguez MT, Soto A, Rodríguez L, Pérez-Landeiro A, Martínez-Lamas L, Nodar A, Crespo M. Effectiveness of ceftazidime/avibactam as salvage therapy for treatment of infections due to OXA-48 carbapenemase-producing Enterobacteriaceae. J Antimicrob Chemother. 2018 Nov;73(11):3170–5. PMID: 30099490. DOI: 10.1093/jac/dky295. http://www.ncbi.nlm.nih.gov/pubmed/30099490
Enlace

Panel de expertos de GeSIDA (Manuel Crespo – Coord; Antonio Ocampo). Documento de consenso de GeSIDA sobre control y monitorización de la infección por VIH (2018). Crespo-Casal M, Lozano F (eds.). GESIDA; 2018. http://gesida-seimc.org/wp-content/uploads/2018/01/gesida_DC_Control_y_Monitorizacion_b23_01_18.pdf
Enlace

Berenguer J, Rodríguez-Castellano E, Carrero A, Von Wichmann MA, Montero M, Galindo MJ, Mallolas J, Crespo M, Téllez MJ, Quereda C, Sanz J, Barros C, Tural C, Santos I, Pulido F, Guardiola JM, Rubio R, Ortega E, Montes ML, Jusdado JJ, Gaspar G, Esteban H, Bellón JM, González-García J, GESIDA HIV/HCV Cohort Study Group. Eradication of hepatitis C virus and non-liver-related non-acquired immune deficiency syndrome-related events in human immunodeficiency virus/hepatitis C virus coinfection. Hepatology. 2017 Aug;66(2):344–56. PMID: 28109003. DOI: 10.1002/hep.29071. IF2017: 14.079; D1. http://www.ncbi.nlm.nih.gov/pubmed/28109003
Enlace

Crespo M, Navarro J, Moreno S, Sanz J, Márquez M, Zamora J, Ocampo A, Iribaren JA, Rivero A, Llibre JM. Hepatic safety of maraviroc in HIV-1-infected patients with hepatitis C and/or B co-infection. The Maraviroc Cohort Spanish Group. Enferm Infecc Microbiol Clin. 2017 Oct;35(8):493–8. PMID: 27061975. DOI: 10.1016/j.eimc.2016.02.029. IF2017: 1.707; Q3. http://www.ncbi.nlm.nih.gov/pubmed/27061975
Enlace

de Mendoza C, Caballero E, Aguilera A, Requena S, de Lejarazu RO, Pirón M, González R, Jiménez A, Roc L, Treviño A, Benito R, Fernández-Alonso M, Aguinaga A, Rodríguez C, García-Costa J, Blanco L, Ramos JM, Calderón E, Eirós JM, Sauleda S, Barreiro P, Soriano V, Spanish HTLV Network (Morano L; Pérez-Castro S; Poveda E). Human T-lymphotropic virus type 1 infection and disease in Spain. AIDS. 2017 Jul;31(12):1653–63. PMID: 28700391. DOI: 10.1097/QAD.0000000000001527. IF2017: 4.914; Q1. http://www.ncbi.nlm.nih.gov/pubmed/28700391
Enlace

Grau-Expósito J, Serra-Peinado C, Miguel L, Navarro J, Curran A, Burgos J, Ocaña I, Ribera E, Torrella A, Planas B, Badía R, Castellví J, Falcó V, Crespo M, Buzon MJ. A Novel Single-Cell FISH-Flow Assay Identifies Effector Memory CD4+ T cells as a Major Niche for HIV-1 Transcription in HIV-Infected Patients. Prasad VR (ed.). MBio. 2017 Sep;8(4):e00876-17. PMID: 28698276. DOI: 10.1128/mBio.00876-17. IF2017: 6.689; Q1. http://www.ncbi.nlm.nih.gov/pubmed/28698276
Enlace

Iribarren Díaz M, Ocampo Hermida A, González-Carreró Fojón J, Longueira Suárez R, Rivera Gallego A, Casal Núñez E, Ocampo Álvarez A, Cachay ER. Preliminary results of a screening program for anal cancer and its precursors for HIV-infected men who have sex with men in Vigo-Spain. Rev Esp Enferm Dig. 2017 Apr;109(4):242–9. PMID: 28229612. DOI: 10.17235/reed.2017.4274/2016. IF2017: 1.632; Q4. http://www.ncbi.nlm.nih.gov/pubmed/28229612
Enlace

Lopez Diez E, Perez S, Inarrea A, de la Orden A, Castro MM, Almuster S, Tortolero L, Rodriguez M, Montero R, Ojea A, López Diez E, Pérez S, Iñarrea A, de la Orden A, Castro MM, Almuster S, Tortolero L, Rodríguez M, Montero R, Ojea A. Prevalence and concordance of high-risk papillomavirus infection in male sexual partners of women diagnosed with high grade cervical lesions. Enferm Infecc Microbiol Clin. 2017 May;35(5):273–7. PMID: 27004428. DOI: 10.1016/j.eimc.2016.02.014. IF2017: 1.707; Q3. http://www.ncbi.nlm.nih.gov/pubmed/27004428
Enlace

Mateos-Lindemann ML, Pérez-Castro S, Rodríguez-Iglesias M, Pérez-Gracia MT. Microbiological diagnosis of human papilloma virus infection. Enferm Infecc Microbiol Clin. 2017 Nov;35(9):593–602. PMID: 27353835. DOI: 10.1016/j.eimc.2016.05.008. IF2017: 1.707; Q3. http://www.ncbi.nlm.nih.gov/pubmed/27353835
Enlace

Moreno S, Antela A, García F, Del Amo J, Boix V, Coll P, Fortuny C, Sirvent JLG, Gutiérrez F, Iribarren JA, Llibre JM, Quirós JCLB de, Losa JE, Lozano A, Meulbroek M, Olalla J, Pujol F, Pulido F, Crespo Casal M, García JG, Aldeguer JL, Molina JAP, Podzamczer Palter D, Román AR, Grupo Redactor de GESIDA/SEIMC. Executive summary: Pre-exposure prophylaxis for prevention of HIV infection in adults in Spain: July 2016. Enferm Infecc Microbiol Clin. 2017 Jun;35(6):377–83. PMID: 28236498. DOI: 10.1016/j.eimc.2016.11.016. IF2017: 1.707; Q3. http://www.ncbi.nlm.nih.gov/pubmed/28236498
Enlace

Navarro J, Laguno M, Vilchez HH, Guardiola JM, Carrion JA, Force L, Cairó M, Cifuentes C, Vilaró J, Cucurull J, Marco A, Roget M, Erice E, Crespo M, Catalano-Balear Study Group. Efficacy and safety of direct antiviral agents in a cohort of cirrhotic HCV/HIV-coinfected patients. J Antimicrob Chemother. 2017 Oct;72(10):2850–6. PMID: 29091196. DOI: 10.1093/jac/dkx223. IF2017: 5.217; D1. http://www.ncbi.nlm.nih.gov/pubmed/29091196
Enlace

Pernas B, Rego-Pérez I, Tabernilla A, Balboa V, Relaño S, Grandal M, Crespo M, Mena Á, Castro-Iglesias Á, Blanco FJ, Poveda E. Plasma mitochondrial DNA levels are inversely associated with HIV-RNA levels and directly with CD4 counts: potential role as a biomarker of HIV replication. J Antimicrob Chemother. 2017 Nov;72(11):3159–62. PMID: 28961892. DOI: 10.1093/jac/dkx272. IF2017: 5.217; D1. http://www.ncbi.nlm.nih.gov/pubmed/28961892
Enlace

Poveda E, Crespo M. When is Early Antiretroviral Therapy Early Enough for HIV Remission? AIDS Rev. 2017 Apr;19(2):113–4. PMID: 28534887. IF2017: 2.775; Q2. http://www.ncbi.nlm.nih.gov/pubmed/28534887
Enlace

Poveda E, Puoti M, García-Deltoro M, Pineda JA, Téllez F, Granados R, Morano L, García F, Grupo de Estudio de Hepatitis Víricas (GEHEP). News on Viral Hepatitis in HIV: Update from the 2016 GEHEP Conference. AIDS Rev. 2017 Jan;19(1):47–53. PMID: 28182613. IF2017: 2.775; Q2. http://www.ncbi.nlm.nih.gov/pubmed/28182613
Enlace

Rivero A, Pérez-Molina JA, Blasco AJ, Arribas JR, Crespo M, Domingo P, Estrada V, Iribarren JA, Knobel H, Lázaro P, López-Aldeguer J, Lozano F, Moreno S, Palacios R, Pineda JA, Pulido F, Rubio R, de la Torre J, Tuset M, Gatell JM. Costs and cost-efficacy analysis of the 2016 GESIDA/Spanish AIDS National Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults. Enferm Infecc Microbiol Clin. 2017 Feb;35(2):88–99. PMID: 27459919. DOI: 10.1016/j.eimc.2016.06.013. IF2017: 1.707; Q3. http://www.ncbi.nlm.nih.gov/pubmed/27459919
Enlace

Rodríguez-Da Silva A, Miralles C, Ocampo A, Valverde D. [Prevalence study of the genetic markers associated with slow progression of human inmunodefiency virus type 1 in the Galician population (Northwest of Spain)]. Enferm Infecc Microbiol Clin. 2017 Feb;35(2):104–7. PMID: 26100217. DOI: 10.1016/j.eimc.2015.04.006. IF2017: 1.707; Q3; JCR-CAT: MICROBIOLOGY. http://www.ncbi.nlm.nih.gov/pubmed/26100217
Enlace

Rodríguez-Osorio I, Cid P, Morano L, Castro Á, Suárez M, Delgado M, Margusino L, Meijide H, Pernas B, Tabernilla A, Pedreira JD, Mena Á, Poveda E. Real life experience with direct-acting antivirals agents against hepatitis C infection in elderly patients. J Clin Virol. 2017 Mar;88:58–61. PMID: 28183063. DOI: 10.1016/j.jcv.2017.01.003. IF2017: 3.101; Q2. http://www.ncbi.nlm.nih.gov/pubmed/28183063
Enlace

Serrano-Villar S, Hernández-Novoa B, de Benito A, Del Romero J, Ocampo A, Blanco JR, Masiá M, Sendagorta E, Sanz G, Moreno S, Pérez-Molina JA. Screening for precancerous anal lesions with P16/Ki67 immunostaining in HIV-infected MSM. Grce M (ed.). PLoS One. 2017 Nov;12(11):e0188851. PMID: 29190817. DOI: 10.1371/journal.pone.0188851. IF2017: 2.766; Q1. http://www.ncbi.nlm.nih.gov/pubmed/29190817
Enlace

Sousa Dominguez A, Pérez-Rodríguez MT, Nodar A, Martinez-Lamas L, Perez-Landeiro A, Crespo Casal M. Successful treatment of MDR Pseudomonas aeruginosa skin and soft-tissue infection with ceftolozane/tazobactam. J Antimicrob Chemother. 2017 Dec;72(4):1262–3. PMID: 27999042. DOI: 10.1093/jac/dkw526. IF2017: 5.217; D1. http://www.ncbi.nlm.nih.gov/pubmed/27999042
Enlace

Panel de expertos AEEH/SEIMC (Manuel Crespo). Guías AEEH/SEIMC de manejo de la Hepatitis C. Pineda JA, Rivero A, Forns X, Calleja JL (eds.). AEEH/SEIMC; 2017. http://aeeh.es/wp-content/uploads/2017/03/documento-consenso.pdf
Enlace

Blanco-Pérez JJ, Pérez González A, Morano Amado LE, Guerra Vales JL, Vázquez Gallardo R, Salgado Barreira Á, Cruz Carmona MJ, González Barcala FJ. Clinical Significance of Environmental Mycobacteria Isolated From Respiratory Specimens of Patients With and Without Silicosis. Arch Bronconeumol. 2016 Mar;52(3):145–50. PMID: 26304492. DOI: 10.1016/j.arbres.2015.07.007. IF2016: 2.979; Q2. http://www.ncbi.nlm.nih.gov/pubmed/26304492
Enlace

Ferenci P, Caruntu FA, Lengyel G, Messinger D, Bakalos G, Flisiak R, TriCo, Study Group (L MORANO). Boceprevir Plus Peginterferon Alfa-2a/Ribavirin in Treatment-Naïve Hepatitis C Virus Genotype 1 Patients: International Phase IIIb/IV TriCo Trial. Infect Dis Ther. 2016 Jun;5(2):113–24. PMID: 27228998. DOI: 10.1007/s40121-016-0110-5. IF2016: N/A. http://www.ncbi.nlm.nih.gov/pubmed/27228998
Enlace

Fernández-García A, Delgado E, Cuevas MT, Vega Y, Montero V, Sánchez M, Carrera C, López-Álvarez MJ, Miralles C, Pérez-Castro S, Cilla G, Hinojosa C, Pérez-Álvarez L, Thomson MM. Identification of an HIV-1 BG Intersubtype Recombinant Form (CRF73_BG), Partially Related to CRF14_BG, Which Is Circulating in Portugal and Spain. PLoS One. 2016;11(2):e0148549. PMID: 26900693. DOI: 10.1371/journal.pone.0148549. IF2016: 2.806; Q1. http://www.ncbi.nlm.nih.gov/pubmed/26900693
Enlace

Geskus RB, González C, Torres M, Del Romero J, Viciana P, Masiá M, Blanco JR, Iribarren M, De Sanjosé S, Hernández-Novoa B, Ortiz M, Del Amo J, CoRIS-HPV Study Group. Incidence and clearance of anal high-risk human papillomavirus in HIV-positive men who have sex with men: estimates and risk factors. AIDS. 2016 Jan;30(1):37–44. PMID: 26355673. DOI: 10.1097/QAD.0000000000000874. IF2016: 5.003; Q1. http://www.ncbi.nlm.nih.gov/pubmed/26355673
Enlace

Iribarren JA, Rubio R, Aguirrebengoa K, Arribas JR, Baraia-Etxaburu J, Gutiérrez F, Lopez Bernaldo de Quirós JC, Losa JE, Miró JM, Moreno S, Pérez Molina J, Podzamczer D, Pulido F, Riera M, Rivero A, Sanz Moreno J, Amador C, Antela A, Arazo P, Arrizabalaga J, Bachiller P, Barros C, Berenguer J, Caylá J, Domingo P, Estrada V, Knobel H, Locutura J, López Aldeguer J, Llibre JM, Lozano F, Mallolas J, Malmierca E, Miralles C, Miralles P, Muñoz A, Ocampo A, Olalla J, Pérez I, Pérez Elías MJ, Pérez Arellano JL, Portilla J, Ribera E, Rodríguez F, Santín M, Sanz Sanz J, Téllez MJ, Torralba M, Valencia E, Von Wichmann MA, GESIDA/SEIMC Writing Committee. Executive summary: Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015. Enferm Infecc Microbiol Clin. 2016 Oct;34(8):517–23. PMID: 27056581. DOI: 10.1016/j.eimc.2016.02.025. IF2016: 1.714; Q3. http://www.ncbi.nlm.nih.gov/pubmed/27056581
Enlace

Iribarren JA, Rubio R, Aguirrebengoa K, Arribas JR, Baraia-Etxaburu J, Gutiérrez F, Lopez Bernaldo de Quirós JC, Losa JE, Miró JM, Moreno S, Pérez Molina J, Podzamczer D, Pulido F, Riera M, Rivero A, Sanz Moreno J, Amador C, Antela A, Arazo P, Arrizabalaga J, Bachiller P, Barros C, Berenguer J, Caylá J, Domingo P, Estrada V, Knobel H, Locutura J, López Aldeguer J, Llibre JM, Lozano F, Mallolas J, Malmierca E, Miralles C, Miralles P, Muñoz A, Ocampo A, Olalla J, Pérez I, Pérez Elías MJ, Pérez Arellano JL, Portilla J, Ribera E, Rodríguez F, Santín M, Sanz Sanz J, Téllez MJ, Torralba M, Valencia E, Von Wichmann MA, GESIDA/SEIMC Writing Committee. Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015. Enferm Infecc Microbiol Clin. 2016 Oct;34(8):516.e1-516.e18. PMID: 26976381. DOI: 10.1016/j.eimc.2016.02.004. IF2016: 1.714; Q3. http://www.ncbi.nlm.nih.gov/pubmed/26976381
Enlace

Jensen DM, Asselah T, Dieterich D, Foster GR, Sulkowski MS, Zeuzem S, Mantry P, Yoshida EM, Moreno C, Ouzan D, Wright M, Morano LE, Buynak R, Bourlière M, Hassanein T, Nishiguchi S, Kao J-H, Omata M, Paik SW, Wong DK, Tam E, Kaita K, Feinman SV, Stern JO, Scherer J, Quinson A-M, Voss F, Gallivan J-P, Böcher WO, Ferenci P. Faldaprevir, pegylated interferon, and ribavirin for treatment-naïve HCV genotype-1: pooled analysis of two phase 3 trials. Ann Hepatol. 2016 Apr;15(3):333–49. PMID: 27049487. DOI: 10.5604/16652681.1198803. IF2016: 1.678; Q4. http://www.ncbi.nlm.nih.gov/pubmed/27049487
Enlace

Marcellin P, Ahn SH, Chuang W-L, Hui AJ, Tabak F, Mehta R, Petersen J, Lee C-M, Ma X, Caruntu FA, Tak WY, Elkhashab M, Lin L, Wu G, Martins EB, Charuworn P, Yee LJ, Lim SG, Foster GR, Fung S, Morano L, Samuel D, Agarwal K, Idilman R, Strasser SI, Buti M, Gaeta GB, Papatheodoridis G, Flisiak R, Chan HLY. Predictors of response to tenofovir disoproxil fumarate plus peginterferon alfa-2a combination therapy for chronic hepatitis B. Aliment Pharmacol Ther. 2016 Nov;44(9):957–66. PMID: 27629859. DOI: 10.1111/apt.13779. IF2016: 7.286; D1. http://www.ncbi.nlm.nih.gov/pubmed/27629859
Enlace

Márquez A, Fernández-Aranguren T, Witte T, González-Gay MA, Martín J, Spanish GCA Group, Spanish Scleroderma Group (Mayka Freire; Adrián Sousa). LILRA3 deficiency is not involved in the giant cell arteritis and systemic sclerosis predisposition. Clin Exp Rheumatol. 2016;34 Suppl 1(5):208–9. PMID: 27462831. IF2016: 2.634; Q3. http://www.ncbi.nlm.nih.gov/pubmed/27462831
Enlace

Pérez Parente D, Suárez Santamaría M, Suárez Ordóñez S, Morano Amado LE. Pulmonary sarcoidosis in the context of a telaprevir-based triple therapy for hepatitis C. Rev Port Pneumol. 2016 Jan;22(1):57–9. PMID: 26422338. DOI: 10.1016/j.rppnen.2015.08.004. IF2016: 1.560; Q4. http://www.ncbi.nlm.nih.gov/pubmed/26422338
Enlace

Poveda E, Crespo M. New Strategies for a Comprehensive Fight Against HIV Infection using Monoclonal Antibody Therapy. AIDS Rev. 2016 Jul;18(3):166. PMID: 27721508. IF2016: 3.195; Q2. http://www.ncbi.nlm.nih.gov/pubmed/27721508
Enlace

Riera M, Esteban H, Suarez I, Palacios R, Lozano F, Blanco JR, Valencia E, Ocampo A, Amador C, Frontera G, vonWichmann-de Miguel MA, GESIDA Study Group of the HIV quality indicators. [Validation and adhesion to GESIDA quality indicators in patients with HIV infection]. Enferm Infecc Microbiol Clin. 2016 Jun;34(6):346–52. PMID: 26530224. DOI: 10.1016/j.eimc.2015.09.003. IF2016: 1.714; Q3. http://www.ncbi.nlm.nih.gov/pubmed/26530224
Enlace

Rojas J, Lonca M, Imaz A, Estrada V, Asensi V, Miralles C, Domingo P, Montero M, del Rio L, Fontdevila J, Perez I, Cruceta A, Gatell JM, Arnedo M, Martínez E. Improvement of lipoatrophy by switching from efavirenz to lopinavir/ritonavir. HIV Med. 2016 May;17(5):340–9. PMID: 27089862. DOI: 10.1111/hiv.12314. IF2016: 3.257; Q2. http://www.ncbi.nlm.nih.gov/pubmed/27089862
Enlace

Serrano-Villar S, Gutiérrez F, Miralles C, Berenguer J, Rivero A, Martínez E, Moreno S. Human Immunodeficiency Virus as a Chronic Disease: Evaluation and Management of Nonacquired Immune Deficiency Syndrome-Defining Conditions. Open forum Infect Dis. 2016 Apr;3(2):ofw097. PMID: 27419169. DOI: 10.1093/ofid/ofw097. IF2016: N/A. http://www.ncbi.nlm.nih.gov/pubmed/27419169
Enlace

Vega Y, Delgado E, de la Barrera J, Carrera C, Zaballos Á, Cuesta I, Mariño A, Ocampo A, Miralles C, Pérez-Castro S, Álvarez H, López-Miragaya I, García-Bodas E, Díez-Fuertes F, Thomson MM. Sequence Analysis of In Vivo-Expressed HIV-1 Spliced RNAs Reveals the Usage of New and Unusual Splice Sites by Viruses of Different Subtypes. Buratti E (ed.). PLoS One. 2016 Jun;11(6):e0158525. PMID: 27355361. DOI: 10.1371/journal.pone.0158525. IF2016: 2.806; Q1. http://www.ncbi.nlm.nih.gov/pubmed/27355361
Enlace

Viciana P, Ocampo A, Hevia H, Palazuelos M, Ledesma F. Sociodemographic and clinical factors associated with the preference between NNRTIs and PIs for the initial treatment of HIV infection: Perfil-es study. AIDS Care. 2016 Oct;28(10):1321–6. PMID: 27140483. DOI: 10.1080/09540121.2016.1173640. IF2016: 1.824; Q2. http://www.ncbi.nlm.nih.gov/pubmed/27140483
Enlace

Crespo-Casal M. Infecciones causadas por el virus del herpes simple y de la Varicela-Zóster. In: Rozman Borstnar C, Cardellach Lo?pez F (eds.). Farreras-Rozman Medicina Interna (XVIII Edición). 18th ed. Barcelona: Elsevier Health Sciences Spain; 2016. p. 2313–6. ISBN: 978-84-9022-996-5. http://media.axon.es/pdf/109425.pdf
Enlace

Grupo Redactor de GESIDA/PNS (Manuel Crespo). Documento de consenso de GeSIDA/Plan Nacional sobre el Sida respecto al tratamiento antirretroviral en adultos infectados por el virus de la inmunodeficiencia humana (Actualización 2016). Rivero A, Polo R, Pérez-Molina JA (eds.). GESIDA, PNS; 2016.

Álvarez-Argüelles ME, de Oña-Navarro M, Rojo-Alba S, Torrens-Muns M, Junquera-Llaneza ML, Antonio-Boga J, Pérez-Castro S, Melón-García S. Quantification of human papilloma virus (HPV) DNA using the Cobas 4800 system in women with and without pathological alterations attributable to the virus. J Virol Methods. 2015 Sep;222:95–102. PMID: 26057221. DOI: 10.1016/j.jviromet.2015.05.016. IF2015: 1.508; Q3. http://www.ncbi.nlm.nih.gov/pubmed/26057221
Enlace

Delgado E, Cuevas MT, Domínguez F, Vega Y, Cabello M, Fernández-García A, Pérez-Losada M, Castro MÁ, Montero V, Sánchez M, Mariño A, Álvarez H, Ordóñez P, Ocampo A, Miralles C, Pérez-Castro S, López-Álvarez MJ, Rodríguez R, Trigo M, Diz-Arén J, Hinojosa C, Bachiller P, Hernáez-Crespo S, Cisterna R, Garduño E, Pérez-Álvarez L, Thomson MM. Phylogeny and Phylogeography of a Recent HIV-1 Subtype F Outbreak among Men Who Have Sex with Men in Spain Deriving from a Cluster with a Wide Geographic Circulation in Western Europe. PLoS One. 2015 Nov;10(11):e0143325. PMID: 26599410. DOI: 10.1371/journal.pone.0143325. IF2015: 3.057; Q1. http://www.ncbi.nlm.nih.gov/pubmed/26599410
Enlace

Pérez-Molina JA, Pulido F, Comité de expertos del Grupo para el Estudio del Sida (GESIDA) de la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC) [Celia Miralles]. [How is the implementation of the new legal framework for health care affecting HIV-infected immigrants in an irregular situation in Spain?]. Enferm Infecc Microbiol Clin. 2015 Aug;33(7):437–45. PMID: 25553717. DOI: 10.1016/j.eimc.2014.10.017. http://www.ncbi.nlm.nih.gov/pubmed/25553717
Enlace

Pérez-Rodríguez MT, Sousa A, Martínez-Cueto P, Ocampo-Hermida A. HIV encephalitis related to the development of a discordant resistant virus in CNS. Clin Microbiol Infect. 2015 Aug;21(8):e59-60. PMID: 25980354. DOI: 10.1016/j.cmi.2015.05.003. IF2015: 4.575; Q1. http://www.ncbi.nlm.nih.gov/pubmed/25980354
Enlace

Poveda E, Wyles D, Morano L, Pineda JA, García F, Grupo de Estudio de Hepatitis Víricas (GEHEP), E P, D W, L M, JA P, F G, GEHEP. News on HIV-HCV coinfection: Update from the 2015 GEHEP conference. AIDS Rev. 2015 Oct;17(4):231–7. PMID: 26616846. IF2015: 2.068; Q3. http://www.ncbi.nlm.nih.gov/pubmed/26616846
Enlace

Feijoo J, Eirea M, Limeres J, Abeleira M, Ramos I, Ocampo A, Diz P. HCV clearance from saliva of HIV-HCV-coinfected patients on treatment with interferon plus ribavirin. Oral Dis. 2014 Apr;20(3):313–8. PMID: 23607445. DOI: 10.1111/odi.12116. IF: 2.427; Q1. http://www.ncbi.nlm.nih.gov/pubmed/23607445
Enlace

Garcia F, Poveda E, Pérez-Elías MJ, Quero JH, Ribas MA, Martínez-Madrid OJ, Flores J, Crespo M, Gutiérrez F, García-Deltoro M, Imaz A, Ocampo A, Artero A, Blanco F, Bernal E, Pasquau J, Mínguez-Gallego C, Pérez N, Aiestarán A, Paredes R. Genotypic tropism testing in proviral DNA to guide maraviroc initiation in aviremic subjects: 48-week analysis of the PROTEST study. J Int AIDS Soc. 2014 Jan;17(4 Suppl 3):19520. PMID: 25394029. DOI: 10.7448/ias.17.4.19520. IF: 5.090; Q1. http://www.ncbi.nlm.nih.gov/pubmed/25394029
Enlace

Martínez E, Jódar Gimeno E, Reyes García R, Carpintero P, Casado JL, Del Pino Montes J, Domingo Pedrol P, Estrada V, Maalouf J, Negredo E, Ocampo A, Muñoz-Torres M, Grupo de Estudio de Sida, Sociedad Española de Endocrinología y Nutrición, Sociedad Española de Investigación Ósea y del Metabolismo Mineral, Sociedad Española de Fractura Osteoporótica. [Consensus statement: recommendations for the management of metabolic bone disease in human immunodeficiency virus patients]. Enferm Infecc Microbiol Clin. 2014 Apr;32(4):250–8. PMID: 24332711. DOI: 10.1016/j.eimc.2013.07.008. IF: 2.172; Q3. http://www.ncbi.nlm.nih.gov/pubmed/24332711
Enlace

Pérez-Castro S, Lorenzo-Mahía Y, Iñarrea Fernández A, Lamas-González MJ, Sarán-Díez MT, Rubio-Alarcón J, Reboredo-Reboredo MC, Mosteiro-Lobato S, López-Miragaya I, Torres-Piñón J, Melón-García S. Cervical intraepithelial neoplasia grade 2 or worse in Galicia, Spain: HPV 16 prevalence and vaccination impact. Enfermedades Infecc y Microbiol cli?nica. 2014 Oct;32(8):479–85. PMID: 24274937. DOI: 10.1016/j.eimc.2013.09.011. IF: 2.172; Q3. http://www.ncbi.nlm.nih.gov/pubmed/24274937
Enlace

Podzamczer D, Imaz A, Perez I, Viciana P, Valencia E, Curto J, Martín T, Castaño M, Rojas J, Espinosa N, Moreno V, Asensi V, Iribarren JA, Clotet B, Force L, Bachiller P, Knobel H, López Bernaldo De Quirós JC, Blanco JR, Rozas N, Vergas J, Ocampo A, Camacho A, Flores J, Gomez-Sirvent JL, KIDAR Study Group. Abacavir/lamivudine plus darunavir/ritonavir in routine clinical practice: a multicentre experience in antiretroviral therapy-naive and -experienced patients. J Antimicrob Chemother. 2014 Sep;69(9):2536–40. PMID: 24833755. DOI: 10.1093/jac/dku157. IF: 5.313; Q1. http://www.ncbi.nlm.nih.gov/pubmed/24833755
Enlace

Podzamczer D, Rozas N, Domingo P, Ocampo A, Van den Eynde E, Deig E, Vergara A, Knobel H, Pasquau J, Antela A, Crespo M, Clotet B, Muñoz J, Fernandez P, Geijo P, de Castro ER, Diz J, Casado A, Torres C. ACTG-HIV symptoms changes in patients switched to RPV/FTC/TDF due to previous intolerance to CART. Interim analysis of the PRO-STR study. J Int AIDS Soc. 2014 Jan;17(4 Suppl 3):19814. PMID: 25397558. IF: 5.090; Q1. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4225323&tool=pmcentrez&rendertype=abstract
Enlace

Viciana P, Ocampo A, Hevia H, Palazuelos M, Ledesma F. [Initial antiretroviral treatment in human immunodeficiency virus-infected patients in Spain: Decisions made in relation to particular immunovirological characteristics (PERFIL-es study)]. Enferm Infecc Microbiol Clin. 2014 Mar;32(2):93–5. PMID: 24144784. DOI: 10.1016/j.eimc.2013.08.002. IF: 2.172; Q3. http://www.ncbi.nlm.nih.gov/pubmed/24144784
Enlace